UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

 

FORM 8-K

 

 

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): July 2, 2021

 

 

 

NUZEE, INC.

(Exact name of registrant as specified in its charter)

 

Nevada   001-39338   38-3849791

(State or other jurisdiction of

incorporation or organization

 

(Commission

File No.)

 

(IRS Employer

Identification No.)

 

1401 Capital Avenue, Suite B, Plano, Texas 75074

(Address of principal executive offices)

 

(760) 295-2408

(Registrant’s telephone number, including area code)

 

N/A

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

[  ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[  ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[  ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[  ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class  

Trading Symbol(s)

 

Name of each exchange on which registered

Common Stock, $0.00001 par value   NUZE   The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company [  ]

 

  If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [  ]

 

 

 

 

 

 

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

Appointment of Patrick Shearer as Chief Financial Officer

 

On July 2, 2021 (the “Commencement Date”), NuZee, Inc. (the “Company”) appointed Patrick Shearer to be the Company’s new Chief Financial Officer, effective immediately.

 

Mr. Shearer, age 53, was employed by Deloitte from 1993 to 2020. Most recently at Deloitte, Mr. Shearer served as Partner, Risk and Financial Advisory Services from 2004 to 2020. During this time, he was responsible for advising corporate and private equity clients on matters including accounting, finance, mergers, acquisitions, divestitures, and capital markets in a variety of industries, including consumer, industrials, services, and technology. Mr. Shearer also held numerous other leadership roles within Deloitte. During his time at Deloitte, Mr. Shearer was based in the firm’s Los Angeles and San Francisco, California and Nagoya and Tokyo, Japan offices. Mr. Shearer earned a Bachelor of Arts degree in economics from the University of California, Los Angeles. He is a licensed certified public accountant in the State of California.

 

On the Commencement Date, the Company entered into an employment agreement with Mr. Shearer in connection with his appointment as Chief Financial Officer (the “Employment Agreement”). Pursuant to the Employment Agreement, Mr. Shearer is entitled to an annual base salary of $250,000 and an annual cash bonus opportunity (“Annual Bonus”), with an annual target bonus opportunity equal to 50% of his base salary (the “Target Bonus”) and an annual maximum bonus opportunity equal to 65% of his base salary, in each case based on the achievement of Company and/or individual performance goals that will be established by the Compensation Committee (the “Compensation Committee”) of the Board of Directors; provided that, depending on results, Mr. Shearer’s actual bonus may be higher or lower than the Target Bonus at the discretion of the Compensation Committee. Mr. Shearer is also eligible to participate in any equity compensation plan of the Company, including the NuZee, Inc. 2019 Stock Incentive Plan, and to receive future equity awards at the Board’s discretion.

 

In addition, pursuant to the Employment Agreement, the Company granted to Mr. Shearer on the Commencement Date an award of options to purchase 200,000 shares of the Company’s common stock. Subject to Mr. Shearer’s continued employment, the options vest as follows: (i) 80,000 options shall vest upon the first anniversary of the Commencement Date; (ii) 60,000 options shall vest upon the second anniversary of the Commencement Date; and (iii) 60,000 options shall vest upon the third anniversary of the Commencement Date. The options have an exercise price of $3.12 per share.

 

Pursuant to the Employment Agreement, if Mr. Shearer resigns for “good reason” or his employment is terminated by the Company without “cause,” each as defined in the Employment Agreement, Mr. Shearer is entitled to receive payment equal to (i) his accrued but unpaid salary for the period through the date of his resignation or termination, plus (ii) an amount equal to one times his annual base salary as then in effect, plus (iii) an amount equal to one times the amount of the Annual Bonus actually paid to Mr. Shearer for the previous fiscal year, prorated based on the number of days actually worked in the fiscal year in which the effective date of termination occurs, plus (iv) reimbursement for premiums paid to continue Mr. Shearer’s health, dental and vision insurance pursuant to the Consolidated Omnibus Reconciliation Act of 1985 (“COBRA”) until the earlier of 18 months or the date on which Mr. Shearer becomes eligible to participate in a group medical plan sponsored by any other employer.

 

 

 

 

Also under the Employment Agreement, if within 12 months following a change in control of the Company, as defined in the Employment Agreement, Mr. Shearer resigns for “good reason” or his employment is terminated by the Company without “cause,” Mr. Shearer is entitled to receive payment equal to (i) his accrued but unpaid salary for the period through the date of his resignation or termination, plus (ii) an amount equal to one and one half times his annual base salary as then in effect, plus (iii) an amount equal to one and one half times the amount of the Annual Bonus actually paid to Mr. Shearer for the previous fiscal year, prorated based on the number of days actually worked in the fiscal year in which the effective date of termination occurs, plus (iv) reimbursement for premiums paid to continue Mr. Shearer’s health, dental and vision insurance pursuant to COBRA until the earlier of 18 months or the date on which Mr. Shearer becomes eligible to participate in a group medical plan sponsored by any other employer.

 

There are no arrangements or understandings between Mr. Shearer and any other persons pursuant to which Mr. Shearer was appointed as an executive officer. Mr. Shearer does not have any family relationships with any director or executive officer of the Company or any person nominated or chosen by the Company to become a director or executive officer of the Company. There are no transactions in which Mr. Shearer has any interest requiring disclosure under Item 404(a) of Regulation S-K.

 

The foregoing description of the Employment Agreement is only a summary and is qualified in its entirety by reference to the full text of the Employment Agreement, a copy of which is filed as Exhibit 10.1 to this Current Report on Form 8-K and is incorporated herein by reference.

 

Severance Agreement with Shanoop Kothari

 

Shanoop Kothari’s resignation from the Company will become effective (the “Separation Date”) on the earlier of August 16, 2021 or the date that the Company’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2021 (the “Form 10-Q”) is filed with the Securities and Exchange Commission (the “SEC”). As a result of the appointment of Mr. Shearer as the Company’s new Chief Financial Officer, Mr. Kothari will no longer perform the duties and responsibilities of the Company’s principal financial officer or principal accounting officer as of the Commencement Date. As of the Commencement Date and until the Separation Date, Mr. Kothari is expected to serve in a role that consists primarily of assisting with the transition to Mr. Shearer as the Company’s new Chief Financial Officer.

 

In connection with Mr. Kothari’s resignation, the Company entered into a Severance Agreement and General Release with Mr. Kothari on July 2, 2021 (the “Severance Agreement”). Pursuant to the Severance Agreement, Mr. Kothari’s 50,737 outstanding restricted shares of common stock will be accelerated to immediately vest on the Separation Date, on the condition that the Company’s Form 10-Q has been timely filed with the SEC on or before August 16, 2021. In addition, Mr. Kothari will be entitled to reimbursement for premiums paid to continue health, dental and vision insurance pursuant to COBRA until the earlier of December 31, 2021 or the date on which Mr. Kothari becomes ineligible to participate in such COBRA coverage.

 

The foregoing description of the Severance Agreement is only a summary and is qualified in its entirety by reference to the full text of the Severance Agreement, a copy of which is filed as Exhibit 10.2 to this Current Report on Form 8-K and is incorporated herein by reference.

 

CEO Cash Bonus for Fiscal Year 2022

 

On July 2, 2021, the Compensation Committee approved the parameters of the cash bonus for Masateru Higashida, the Company’s President and Chief Executive Officer (the “Fiscal Year 2022 Cash Bonus”), for the Company’s next fiscal year ending September 30, 2022 (“fiscal year 2022”). Pursuant to Mr. Higashida’s Executive Employment Agreement dated as of August 15, 2017, the Compensation Committee established the relevant performance metrics and goals for determining the amount of the Fiscal Year 2022 Cash Bonus that Mr. Higashida would be entitled to receive, assuming achievement by the Company of the respective target and maximum performance levels under each metric established for fiscal year 2022. The Fiscal Year 2022 Cash Bonus, if any, payable to Mr. Higashida will be determined by the extent to which the Company achieves certain performance objectives relating to the Company’s net revenues and net cash provided by operating activities in the fiscal year ended September 30, 2022, with a target Fiscal Year 2022 Cash Bonus opportunity of $105,000 and a maximum Fiscal Year 2022 Cash Bonus opportunity of $210,000.

 

 

 

 

CEO Equity Compensation for Fiscal Years 2022, 2023 and 2024

 

In addition, on July 2, 2021, the Compensation Committee approved a grant of nonqualified performance-based options (the “Options”) to Mr. Higashida to purchase 896,743 shares of the Company’s common stock, which represents the maximum number of Options that may be earned if all performance milestones are achieved, as further described below. The Options will vest, if at all, based on the extent to which the Company achieves certain performance objectives relating to the Company’s earnings before income taxes in each of fiscal year 2022 and the fiscal years ending September 30, 2023 (“fiscal year 2023”) and September 30, 2024 (“fiscal year 2024”). Pursuant to the award agreement (the “Award Agreement”), (i) 179,349 Options shall vest, if at all, in fiscal year 2022, (ii) 269,023 Options shall vest, if at all, in fiscal year 2023, and (iii) 448,371 Options shall vest, if at all, in fiscal year 2024, in each case based upon the Company’s achievement of a specified amount of earnings before income taxes in the respective fiscal year. The Options have an exercise price of $3.12 per share. The foregoing description of the Award Agreement is only a summary and is qualified in its entirety by reference to the full text of the form of the Award Agreement. The form of the Award Agreement is filed as Exhibit 10.3 to this Current Report on Form 8-K and is incorporated herein by reference.

 

CEO Bonus Determination for Fiscal Year Ended September 30, 2020

 

Also on July 2, 2021, the Compensation Committee awarded a deferred bonus of $75,000 payable to Mr. Higashida for his service to the Company in the prior fiscal year ended September 30, 2020.

 

Item 7.01. Regulation FD Disclosure.

 

On July 6, 2021, the Company issued a press release announcing the appointment of Mr. Shearer as the Company’s new Chief Financial Officer. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

 

As provided in General Instruction B.2 to Form 8-K, the information furnished in this Item 7.01 shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities under that Section and shall not be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended (the “Securities Act”), or the Exchange Act, except as shall be expressly provided by specific reference in such filing.

 

Cautionary Note Regarding Forward-Looking Statements

 

This Current Report on Form 8-K includes “forward-looking statements” within the meaning of Section 27A of the Securities Act, and Section 21E of the Exchange Act. Forward-looking statements are subject to known and unknown risks and uncertainties, many of which may be beyond the Company’s control. The Company cautions that the forward-looking information presented in this Current Report is not a guarantee of future events, and that actual events and results may differ materially from those made in or suggested by the forward-looking information contained in this Current Report. In addition, forward-looking statements generally can be identified by the use of forward-looking terminology such as “may,” “plan,” “will,” “expect,” “intend,” “estimate,” “anticipate,” “believe” or “continue” or the negative thereof or variations thereon or similar terminology. A number of important factors could cause actual events and results to differ materially from those contained in or implied by the forward-looking statements, including those risk factors set forth in the Company’s filings with the SEC, including the most recent Annual Report on Form 10-K. Any forward-looking information presented herein is made only as of the date of this Current Report, and the Company does not undertake any obligation to update or revise any forward-looking information to reflect changes in assumptions, the occurrence of unanticipated events or otherwise.

 

Item 9.01 Financial Statements and Exhibits.

 

(d) Exhibits

 

Exhibit   Description
10.1   Employment Agreement, dated July 2, 2021, by and between NuZee, Inc. and Patrick Shearer
10.2   Severance Agreement and General Release, dated July 2, 2021, by and between NuZee, Inc. and Shanoop Kothari
10.3   Form of Stock Option Agreement under the NuZee, Inc. 2019 Stock Incentive Plan (Performance-Based).
99.1   Press release, dated July 6, 2021

 

 

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

 

NUZEE, INC.

   
Dated: July 7, 2021 By: /s/ Masateru Higashida
  Name: Masateru Higashida
  Title: Chief Executive Officer and President

 

 

 

 

 

Exhibit 10.1

 

EMPLOYMENT AGREEMENT

 

THIS EMPLOYMENT AGREEMENT (“Agreement”) is entered into as of July 2, 2021, by and between NuZee, Inc., a Nevada Corporation (the “Company”) and Patrick Shearer (“Employee”).

 

A. WHEREAS, the Company is in the business of developing, manufacturing and marketing of high-end consumer coffee products;

 

B. WHEREAS, Employee represents he has the requisite training, experience, knowledge and expertise of a professional chief financial officer, thus enabling Employee to undertake the duties, authority and responsibilities as are consistent with such positions;

 

C. WHEREAS, the Company now believes it is in the interest of the Company and its shareholders to engage Employee as the Company’s Chief Financial Officer (“CFO”);

 

NOW THEREFORE, in consideration of the mutual promises and covenants contained in this Agreement and such other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties agree as follows:

 

1. Recitations. The above recitations are true and correct and are incorporated herein by this reference.

 

2. Employment.

 

2.1 Position of Employment. The Company hereby employs Employee as the CFO, upon all of the terms and conditions hereinafter set forth. Employee shall have such duties, authority and responsibilities as shall be determined from time to time by the CEO and/or President, which duties, authority and responsibilities are consistent with Employee’s position. Employee will conduct his activities in accordance with the high standards of the Company. All actions shall be subject and subordinate to review and approval of the Company’s CEO and/or President and Board of Directors, and in accordance with the terms and conditions as prescribed in the Employee Handbook, as may be revised from time to time. Employees are encouraged to familiarize themselves with the Employee Handbook.

 

2.2 Place of Employment. The principal place of Employee’s employment shall be the Employee’s home address currently located in the State of California; provided that, the Employee may be required from time to time to travel on Company business to the Company’s Vista, California offices.

 

2.3 Devotion of Time. During the term of Employee’s employment, Employee shall devote his full, exclusive business time, ability and attention to the business affairs of the Company and shall use his best efforts to perform faithfully and efficiently such responsibilities.

 

 

 

 

3. Term of Employment.

 

The term of this Agreement shall begin effective July 2, 2021 (the “Commencement Date”) and shall terminate upon the occurrence of any one or more of the following events:

 

3.1 Termination of Employment by the Company for Cause. The Company may terminate Employee’s employment effective immediately, if such termination is for “Cause.” For purposes of this Agreement, “Cause” shall include:

 

(a) death of Employee;

 

(b) a default or breach by Employee of any of the provisions of this Agreement;

 

(c) actions by Employee constituting fraud, embezzlement or dishonesty;

 

(d) furnishing false, misleading, or omissive information or omitting to furnish material information to the Company in the reasonable judgment of the Company;

 

(e) any action which constitutes a breach of the confidentiality and/or trade secrets of the Company;

 

(f) the commission of an act by Employee involving moral turpitude;

 

(g) refusal to follow reasonable and lawful directives of the Company’s CEO and/or President; or

 

(h) to the extent permitted by law, in the event of Employee’s physical or mental disability that prevents him from performing his job duties, with or without a reasonable accommodation, for a period of at least 90 consecutive days in any 12-month period or 120 non-consecutive days in any 12-month period.

 

Upon termination for Cause, the Company shall not be liable for payment of any further compensation or incentive payment other than (i) accrued but unpaid Base Salary and accrued but unused vacation through the effective date of such termination; (ii) reimbursement for any unreimbursed business expenses properly incurred by Employee, which shall be subject to and paid in accordance with the Company’s expense reimbursement policy; and (iii) such employee benefits (including equity compensation), if any, to which Employee may be entitled under the Company’s employee benefit plans as of the termination date (collectively, “Accrued Obligations”). Notwithstanding any termination pursuant to this Section 3.1, the provisions of Sections 6, 7, 8, 9, 10, 11, 12, 13, and 14 of this Agreement shall remain in full force and effect. Notwithstanding the foregoing, Employee shall be entitled to receive all appropriate benefits mandated by the Consolidated Budget Reconciliation Act of 1985 (“COBRA”).

 

3.2 Termination without Cause. Notwithstanding any other provision contained herein, Company may terminate this agreement and Employee’s employment hereunder without Cause and in Company’s sole and absolute discretion by giving Employee fourteen (14) days prior notice thereof.

 

2

 

 

Upon termination without Cause, the Company shall be liable for payment of the Accrued Obligations through and including the effective date of termination. In addition, (A) Company shall pay Employee (i) a lump sum equal to one times Employee’s Base Salary as then in effect, and (ii) an amount equal to one times the amount of the Annual Bonus (as defined below) actually paid to Employee for the fiscal year immediately prior to the fiscal year in which the effective date of termination occurs, prorated based on the number of days actually worked in the fiscal year in which the effective date of termination occurs (calculated as the Annual Bonus that was actually paid to Employee for the fiscal year immediately prior to the fiscal year in which the effective date of termination occurs, multiplied by a fraction, the numerator of which is equal to the number of days the Employee worked in the fiscal year in which the effective date of termination occurs, and the denominator of which is equal to the total number of days in such year), in each case payable on Company’s first regular pay date that is on or after the 60th day following the effective date of termination; (B) for the period beginning on the effective date of termination and ending on the date that is 18 months after the effective date of termination, Company shall reimburse Employee for any premiums that Employee pays pursuant to the Consolidated Omnibus Budget Reconciliation Act of 1985 and/or sections 601 through 608 of COBRA to continue coverage in the Company’s health insurance program for active employees in which Employee and Employee’s dependents participated immediately prior to the effective date of termination, including major medical, dental, and vision, but excluding any self-funded group health plans (each such premium being a “COBRA Premium”); provided, however, that in order to receive a COBRA Premium reimbursement, Employee must timely elect COBRA continuation coverage, pay the applicable COBRA Premium and provide Company with evidence satisfactory to Company of Employee’s having paid the COBRA Premium within 30 days of having paid such COBRA Premium; provided further, however, that no COBRA Premium reimbursement shall be payable if such reimbursement could reasonably be expected to subject Company to sanctions imposed pursuant to Section 2716 of the Public Health Service Act and the related regulations and guidance promulgated thereunder (collectively, including any successor statute, the “PHSA”). Each COBRA Premium reimbursement shall be provided to Employee by Company within 30 days of its receipt of such evidence of the COBRA Premium payment; provided, further, however, that Company shall have no obligation to provide Employee the COBRA Premium reimbursement for any period in which Employee is eligible to participate in a group medical plan sponsored by any other employer. Employee agrees and understands that the payment of any COBRA Premium will remain Employee’s sole responsibility. Notwithstanding any termination pursuant to this Section 3.2, the provisions of Sections 6, 7, 8, 9, 10, 11, 12, 13 and 14 of this Agreement shall remain in full force and effect. Collectively, the payments made under this Section shall be referred to as the “Without Cause Separation Package.”

 

3.3 Termination by Employee. Employee may terminate this Agreement whether for any reason or no reason by giving thirty (30) days written notice to the Company. Upon such termination, Employee shall only be entitled to Accrued Obligations through the effective date of termination. Notwithstanding any termination herein, the provisions of Paragraphs 6, 7, 8, 9, 10, 11, 12, 13 and 14 shall remain in full force and effect.

 

3

 

 

3.4 Resignation by Employee for Good Reason.

 

(a) Notwithstanding the provisions of Section 3.3, in the event that Employee terminates this Agreement by resigning for Good Reason (defined below), in addition to payment of the Accrued Obligations, (A) Company shall pay Employee (i) a lump sum equal to one times Employee’s Base Salary as then in effect, and (ii) an amount equal to one times the amount of the Annual Bonus (as defined below) actually paid to Employee for the fiscal year immediately prior to the fiscal year in which the effective date of termination occurs, prorated based on the number of days actually worked in the fiscal year in which the effective date of termination occurs (calculated as the Annual Bonus that was actually paid to Employee for the fiscal year immediately prior to the fiscal year in which the effective date of termination occurs, multiplied by a fraction, the numerator of which is equal to the number of days the Employee worked in the fiscal year in which the effective date of termination occurs, and the denominator of which is equal to the total number of days in such year), in each case payable on Company’s first regular pay date that is on or after the 60th day following the effective date of termination; (B) for the period beginning on the effective date of termination and ending on the date that is 18 months after the effective date of termination, Company shall reimburse Employee for the COBRA Premium (as defined above); provided, however, that in order to receive a COBRA Premium reimbursement, Employee must timely elect COBRA continuation coverage, pay the applicable COBRA Premium and provide Company with evidence satisfactory to Company of Employee’s having paid the COBRA Premium within 30 days of having paid such COBRA Premium; provided further, however, that no COBRA Premium reimbursement shall be payable if such reimbursement could reasonably be expected to subject Company to sanctions imposed pursuant to Section 2716 of the PHSA. Each COBRA Premium reimbursement shall be provided to Employee by Company within 30 days of its receipt of such evidence of the COBRA Premium payment; provided, further, however, that Company shall have no obligation to provide Employee the COBRA Premium reimbursement for any period in which Employee is eligible to participate in a group medical plan sponsored by any other employer. Employee agrees and understands that the payment of any COBRA Premium will remain Employee’s sole responsibility. Notwithstanding any termination pursuant to this Section 3.4, the provisions of Sections 6, 7, 8, 9, 10, 11, 12, 13 and 14 of this Agreement shall remain in full force and effect. Collectively, the payments made under this Section shall be referred to as the “Good Reason Separation Package.”

 

(b) For purposes of this Agreement, “Good Reason” shall mean (1) the material breach of any of Company’s obligations under this Agreement without Employee’s written consent; (2) the change of Employee’s title or the assignment to Employee of any duties that materially adversely alter the nature or status of Employee’s office, title, and responsibilities, including reporting responsibilities, or action by Company that results in the material diminution of Employee’s position, duties or authorities, from those in effect immediately prior to such change in title, assignment or action, in each case, without Employee’s written consent; or (3) in the event that Employee and Company cannot agree on a relocation package, the relocation of the Employee’s principal place of employment as set forth in Section 2.2 of this Agreement, except for required travel on Company’s business to an extent substantially consistent with Employee’s obligations under this Agreement. To constitute Good Reason, Employee is required to provide notice to Company of the existence of the conditions constituting Good Reason within a period not to exceed ninety (90) days from the initial existence of the condition and Company must be provided a period of at least 30 days during which it may remedy the condition.

 

4

 

 

3.5 After a Change in Control.

 

(a) If Employee terminates his employment with Good Reason or Company terminates Employee’s employment without Cause within twelve (12) months following a Change in Control (as defined below), then in addition to payment of the Accrued Obligations, (A) Company shall pay Employee (i) a lump sum equal to one and a half (1.5) times Employee’s Base Salary as then in effect, and (ii) an amount equal to one and a half (1.5) times the amount of the Annual Bonus (as defined below) actually paid to Employee for the fiscal year immediately prior to the fiscal year in which the effective date of termination occurs, prorated based on the number of days actually worked in the fiscal year in which the effective date of termination occurs (calculated as the Annual Bonus that was actually paid to Employee for the fiscal year immediately prior to the fiscal year in which the effective date of termination occurs, multiplied by a fraction, the numerator of which is equal to the number of days the Employee worked in the fiscal year in which the effective date of termination occurs, and the denominator of which is equal to the total number of days in such year), in each case payable on Company’s first regular pay date that is on or after the 60th day following the effective date of termination; (B) for the period beginning on the effective date of termination and ending on the date that is 18 months after the effective date of termination, Company shall reimburse Employee for the COBRA Premium (as defined above); provided, however, that in order to receive a COBRA Premium reimbursement, Employee must timely elect COBRA continuation coverage, pay the applicable COBRA Premium and provide Company with evidence satisfactory to Company of Employee’s having paid the COBRA Premium within 30 days of having paid such COBRA Premium; provided further, however, that no COBRA Premium reimbursement shall be payable if such reimbursement could reasonably be expected to subject Company to sanctions imposed pursuant to Section 2716 of the PHSA. Each COBRA Premium reimbursement shall be provided to Employee by Company within 30 days of its receipt of such evidence of the COBRA Premium payment; provided, further, however, that Company shall have no obligation to provide Employee the COBRA Premium reimbursement for any period in which Employee is eligible to participate in a group medical plan sponsored by any other employer. Employee agrees and understands that the payment of any COBRA Premium will remain Employee’s sole responsibility. Notwithstanding any termination pursuant to this Section 3.5, the provisions of Sections 6, 7, 8, 9, 10, 11, 12, 13 and 14 of this Agreement shall remain in full force and effect. Collectively, the payments made under this Section shall be referred to as the “CIC Separation Package.”

 

(b) For purposes of this Agreement, the term “Change in Control” means the occurrence of any of the following events: (A) a sale, transfer, disposition or other transaction in which the beneficial owners (as defined in Rules 13d-3 and 13d-5 under the Securities Exchange Act of 1934, as amended), directly or indirectly, of the total voting power of the Common Stock of Company immediately prior to such transaction shall cease to be the beneficial owners, directly or indirectly, of at least 50% of the total voting power of Common Stock of Company immediately after such transaction; (B) the stockholders of Company approve a plan of complete liquidation or dissolution of Company; or (C) there is consummated in one or more transactions an agreement for the sale or disposition by Company of all or substantially all of Company’s consolidated assets, other than any such sale or disposition of assets immediately following which the individuals who comprise the Board immediately prior thereto (or individuals who are elected to the Board with the affirmative vote of a majority of the individuals who comprise the Board immediately prior thereto) constitute at least a majority of the board of directors of (1) any parent of the entity to which such assets are sold or disposed, or (2) if there is no such parent, such entity.

 

5

 

 

3.6 Release. Notwithstanding any other provision in this Agreement to the contrary, Employee shall be eligible to receive the Good Reason Separation Package, the Without Cause Separation Package, or the CIC Separation Package payments pursuant to Sections 3.2, 3.4 or 3.5 (each referred to individually as a “Separation Package”) only if Employee has executed and not revoked a release of all claims in a form acceptable to Company (the “Release”), which Release shall release Company and its affiliates, and the foregoing entities’ respective shareholders, members, partners, officers, managers, directors, fiduciaries, employees, representatives, agents and benefit plans (and fiduciaries of such plans) (collectively referred to as the “Released Parties”) from any and all claims, including any and all causes of action arising out of the Employee’s employment with Company or any of its affiliates or the termination of such employment, but excluding all claims to any Separation Package (or portion thereof) that Employee may have, any claims with respect to any vested benefits, indemnification rights Employee had for any actions or omissions occurring while employed by Company, any claims Employee may have for workers’ compensation benefits, and any other claims against any third party not included amongst the Released Parties. To be entitled to receive a Separation Package, the time period during which Employee can revoke the Release must expire before the 60th day after the effective date of termination. Unless and until Employee has executed and not revoked a Release and the time period during which Employee can revoke the Release has expired, Employee shall have no right to receive a Separation Package. If Employee has not executed without revoking a Release and the time period during which Employee can revoke the Release has not expired before the 60th day after the effective date of termination, Employee shall immediately forfeit his rights to a Separation Package.

 

3.7 Death of Employee. In the event that (1) the Employee is entitled to receive any of the post-termination benefits set forth in this Section 3 following the effective date of his termination, including the Good Reason Separation Package, the Without Cause Separation Package, and the CIC Separation Package payments pursuant to Sections 3.2, 3.4 or 3.5, and (2) the Employee thereafter dies prior to receiving full payment of any such post-termination benefits, then the Employee’s designated beneficiaries (or in the absence of any of Employee’s surviving designated beneficiaries, the Employee’s estate) shall thereafter be entitled to receive payment of any and all remaining unpaid benefits to which the Employee was otherwise entitled.

 

3.8 Compliance with Section 409A. It is the intention of both Company and Employee that the benefits and rights to which Employee could be entitled pursuant to this Agreement comply with Section 409A of the Internal Revenue Code (the “Code”) and the Treasury Regulations and other guidance promulgated or issued thereunder (hereinafter, “Section 409A”), to the extent that the requirements of Section 409A are applicable thereto, and the provisions of this Agreement shall be construed in a manner consistent with that intention. If any benefits or rights constitute “nonqualified deferred compensation” under Section 409A, then the nonqualified deferred compensation shall be subject to the following additional requirements, if and to the extent required to comply with Section 409A:

 

(a) Neither Company nor Employee, individually or in combination, may accelerate any payment or benefit that is subject to Section 409A, except in compliance with Section 409A and the provisions of this Agreement, and no amount that is subject to Section 409A shall be paid prior to the earliest date on which it may be paid without violating Section 409A.

 

(b) For purposes of the foregoing, the terms used within this Section 5(j) have the same meanings as those terms have for purposes of Section 409A, and the limitations set forth herein shall be applied in such manner (and only to the extent) as shall be necessary to comply with any requirements of Section 409A that are applicable to the deferred compensation.

 

6

 

 

(c) For purposes of applying the provisions of Section 409A to this Agreement, and to the extent permissible under Section 409A, each installment payment and each separately identified amount to which Employee is entitled under this Agreement shall, in each case, be treated as a separate payment.

 

(d) Any reimbursements by Company to Employee of any eligible expenses under this Agreement that are not excludable from Employee’s income for Federal income tax purposes (the “Taxable Reimbursements”) shall be made by no later than the last day of Employee’s taxable year immediately following the year in which the expense was incurred. The amount of any Taxable Reimbursements, and the value of any in-kind benefits to be provided to Employee, during any taxable year of Employee shall not affect the expenses eligible for reimbursement, or in-kind benefits to be provided, in any other taxable year of Employee. The right to Taxable Reimbursement, or in-kind benefits, shall not be subject to liquidation or exchange for another benefit.

 

(e) If Employee or Company believes, at any time, that any such benefit or right that is subject to Section 409A does not so comply, the concerned Party shall promptly advise the other and both Parties shall negotiate reasonably and in good faith to amend the terms of such benefits and rights such that they comply with Section 409A (with the most limited possible economic effect on Employee and on Company). Notwithstanding the foregoing, Company makes no representations that the payments and benefits provided under this Agreement comply with Section 409A and in no event shall Company be liable for all or any portion of the taxes, penalties, interest or other expenses that may be incurred by Employee on account of non-compliance with Section 409A.

 

4. Compensation and Benefits.

 

Company shall pay to Employee compensation during the term of this Agreement as initially determined by the CEO and/or President from time to time and as approved by the Compensation Committee (the “Compensation Committee”) of the Board of Directors of the Company; which compensation shall be initially as follows:

 

4.1 Base Salary. Employee shall receive a starting base salary (“Base Salary”) of $250,000 per year payable semi-monthly or in accordance with such other payment schedule as may be approved by the CEO and/or President; it being further understood that at the election of the CEO and/or President, Employee’s Base Salary (and other compensation, as may be applicable) may be revisited in the discretion of the Compensation Committee of the Board of Directors.

 

7

 

 

4.2 Annual Cash Bonus Opportunity.

 

(a) For each complete fiscal year of the employment term, the Employee shall be eligible to receive an annual cash bonus (the “Annual Bonus”). As of the Commencement Date, the Employee’s annual target bonus opportunity shall be equal to 50% of Base Salary (the “Target Bonus”), based on the achievement of Company and/or Employee performance goals established by the Compensation Committee; provided that, depending on results, the Employee’s actual bonus may be higher or lower than the Target Bonus, as determined by the Compensation Committee. If the Company and/or Employee achieves superior performance goals established by the Compensation Committee, then the Employee shall be eligible to receive an Annual Bonus equal to 65% of Base Salary (the “Maximum Bonus”). If target performance goals are not achieved in a respective fiscal year, then the Employee shall not receive an Annual Bonus for such fiscal year, except as may be otherwise determined by the Compensation Committee in its discretion. For the period beginning on the Commencement Date and ending on the last day of the fiscal year ended September 30, 2021 (“Fiscal Year 2021”), the Employee shall be eligible to receive a prorated Annual Bonus for Fiscal Year 2021 (calculated as the Annual Bonus that would have been paid for the entire fiscal year multiplied by a fraction, the numerator of which is equal to the number of days the Employee worked in the applicable fiscal year, and the denominator of which is equal to the total number of days in such year).

 

(b) The Annual Bonus, if any, will be paid within three and a half (3 1/2) months after the end of the applicable fiscal year.

 

(c) The Annual Bonus will be subject to the terms of the Company’s annual bonus plan under which it is granted, if any.

 

(d) In order to be eligible to receive an Annual Bonus, the Employee must be employed by the Company on the last day of the applicable fiscal year for which Annual Bonuses are paid.

 

4.3 Stock Option Grants. As part of the Company team, the Company strongly believes that ownership of the Company by its employees is an important factor to its success. Therefore, as part of Employee’s compensation, and subject to the approval of the Compensation Committee, Employee will be granted the following options to purchase shares of the Company’s common stock (the “Options”), which shall vest pursuant to the terms and conditions set forth below and in the Company’s equity incentive plan, as in effect from time to time:

 

(a) Base Grant of Time-Based Options. On the Commencement Date, Employee shall be granted Options to purchase 200,000 shares of the Company’s common stock with an exercise price equal to the fair market value at the time of grant. Such Options will be on the Company’s customary terms and conditions and, subject to Employee’s continued employment, shall vest as follows: (a) 80,000 Options shall vest upon the first anniversary of the Commencement Date of this Agreement; (b) 60,000 Options shall vest upon the second anniversary of the Commencement Date of this Agreement and (c) 60,000 Options shall vest upon the third anniversary of the Commencement Date of this Agreement.

 

At Company’s election, the foregoing Options may be subject to execution of one or more Stock Option Agreements consistent herewith. The Options will not be formalized until approved by the Compensation Committee.

 

4.4 Employee shall accrue twenty (20) days of vacation during each twelve (12) month period of employment, subject to the terms set forth in the Company’s vacation policy in NuZee, Inc.’s Employee Handbook.

 

8

 

 

4.5 Commencing immediately following the date of Employee’s actual employment, Employee shall be entitled to participate in all employee benefit plans, practices, and programs maintained by the Company, including any health and profit-sharing plans made available to the employees, as in effect from time to time (collectively, “Employee Benefit Plans”), on a basis which is no less favorable than is provided to other similarly situated executives of the Company. The Company reserves the right to amend or terminate any Employee Benefit Plans at any time in its sole discretion, subject to the terms of such Employee Benefit Plan and applicable law.

 

4.6 Employee shall be entitled to receive reimbursement for any expenses made on behalf of Company, which expenditures must first have been pre-approved in writing. Employee’s pre-approved travel expenses and accommodations will be reimbursed or paid by Company.

 

5. Vacation Policy. The purpose of the Company’s vacation policy is to allow its employees to take periodic breaks from work and is more fully described in the NuZee, Inc. Employee Handbook.

 

6. Nonsolicitation. During the period of his employment by the Company and for a period of one (1) year after termination of such employment (for any reason, whether voluntarily or involuntarily), Employee agrees that he will not directly or indirectly, whether alone or for himself or for any other person, business, partnership, association, firm, company or corporation, call upon, solicit, divert or take away or attempt to solicit, divert or take away, any of the employees of Company in existence at the time of the termination of Employee’s employment.

 

7. Confidential Information. Employee understands and acknowledges that during the term of employment, Employee will have access to and learn about Confidential Information, as defined below.

 

7.1 Confidential Information Defined.

 

(a) Definition. For purposes of this Agreement, “Confidential Information” includes, but is not limited to, all information not generally known to the public, in spoken, printed, electronic or any other form or medium, relating directly or indirectly to: business processes, practices, methods, policies, plans, publications, documents, research, operations, services, strategies, techniques, agreements, contracts, terms of agreements, transactions, potential transactions, negotiations, pending negotiations, know-how, trade secrets, computer programs, computer software, applications, operating systems, software design, web design, work-in-process, databases, device configurations, embedded data, compilations, metadata, technologies, manuals, records, articles, systems, material, sources of material, supplier information, vendor information, financial information, results, accounting information, accounting records, legal information, marketing information, advertising information, pricing information, credit information, design information, payroll information, staffing information, personnel information, employee lists, supplier lists, vendor lists, developments, reports, internal controls, security procedures, graphics, drawings, sketches, market studies, sales information, revenue, costs, formulae, notes, communications, algorithms, product plans, designs, styles, models, ideas, audiovisual programs, inventions, unpublished patent applications, original works of authorship, discoveries, experimental processes, experimental results, specifications, customer information, customer lists, client information, client lists, manufacturing information, factory lists, distributor lists, and buyer lists of the Company or its businesses or any existing or prospective customer, supplier, investor or other associated third party or of any other person or entity that has entrusted information to the Company in confidence.

 

9

 

 

Employee understands that the above list is not exhaustive, and that Confidential Information also includes other information that is marked or otherwise identified as confidential or proprietary, or that would otherwise appear to a reasonable person to be confidential or proprietary in the context and circumstances in which the information is known or used.

 

Employee understands and agrees that Confidential Information includes information developed by Employee in the course of employment by the Company as if the Company furnished the same Confidential Information to Employee in the first instance. Confidential Information shall not include information that is generally available to and known by the public at the time of disclosure to Employee; provided that, such disclosure is through no direct or indirect fault of Employee or person(s) acting on Employee’s behalf.

 

(b) Company Creation and Use of Confidential Information. Employee understands and acknowledges that Company has invested, and continues to invest, substantial time, money, and specialized knowledge into developing its resources, creating a customer base, generating customer and potential customer lists, training its employees, and improving its offerings in the field of high-end consumer coffee products. Employee understands and acknowledges that as a result of these efforts, the Company has created, and continues to use and create Confidential Information. This Confidential Information provides the Company with a competitive advantage over others in the marketplace.

 

(c) Disclosure and Use Restrictions.

 

Employee agrees and covenants: (i) to treat all Confidential Information as strictly confidential; (ii) not to directly or indirectly disclose, publish, communicate, or make available Confidential Information, or allow it to be disclosed, published, communicated, or made available, in whole or part, to any entity or person whatsoever (including other employees of the Company) not having a need to know and authority to know and use the Confidential Information in connection with the business of the Company and, in any event, not to anyone outside of the direct employ of the Company except as required in the performance of Employee’s authorized employment duties to the Company or with the prior consent of CEO and/or President acting on behalf of the Company in each instance (and then, such disclosure shall be made only within the limits and to the extent of such duties or consent); and (iii) not to access or use any Confidential Information, and not to copy any documents, records, files, media, or other resources containing any Confidential Information, or remove any such documents, records, files, media, or other resources from the premises or control of the Company, except as required in the performance of Employee’s authorized employment duties to the Company.

 

(d) Permitted Disclosures. Nothing herein shall be construed to prevent disclosure of Confidential Information as may be required by applicable law or regulation, or pursuant to the valid order of a court of competent jurisdiction or an authorized government agency, provided that the disclosure does not exceed the extent of disclosure required by such law, regulation, or order.

 

10

 

 

(e) Notice of Immunity Under the Economic Espionage Act of 1996, as amended by the Defend Trade Secrets Act of 2016 (“DTSA”). Notwithstanding any other provision of this Agreement:

 

(I) Employee will not be held criminally or civilly liable under any federal or state trade secret law for any disclosure of a trade secret that:

 

(i) is made (1) in confidence to a federal, state, or local government official, either directly or indirectly, or to an attorney; and (2) solely for the purpose of reporting or investigating a suspected violation of law, or

 

(ii) is made in a complaint or other document filed under seal in a lawsuit or other proceeding.

 

(f) If Employee files a lawsuit for retaliation by the Company for reporting a suspected violation of law, Employee may disclose the Company’s trade secrets to Employee’s attorney and use the trade secret information in the court proceeding if Employee:

 

(I) files any document containing trade secrets under seal; and

 

(II) does not disclose trade secrets, except pursuant to court order.

 

8. Absence of Conflicting Agreements. Employee understands the Company does not desire to acquire from him any trade secrets, know-how or confidential business information that he may have acquired from others. Accordingly, Employee represents and warrants that he is free to divulge to Company, without any obligation to, or violation of any right of others, any and all information, practices and techniques which he will use, describe, demonstrate or divulge or in any other manner make known to the Company during the course of his employment Employee represents that he is not bound by any agreement or any other existing or previous business relationship which conflicts with or prevents the full performance of his duties and obligations to the Company during his course of employment by Company.

 

9. Remedies Upon Breach. Employee agrees that any breach of this Agreement by him could cause irreparable damage to Company and that in the event of such breach, Company shall have, in addition to any and all remedies at law, the right to an injunction, specific performance or other equitable relief to prevent any violation or threatened violation of Employee’s obligations hereunder.

 

10. No Employment Obligation. Employee understands that this Agreement does not create any obligation on the Company or any other person to continue his employment. The Employee understands that the Employee is an employee subject to termination as set forth in Paragraph 3 above.

 

11

 

 

11. Business Opportunities. During the term of this Agreement, Employee agrees to bring all business opportunities to the Company relating to or otherwise associated with the business or businesses then conducted by the Company or any affiliate thereof, or business or businesses proposed to be conducted by the Company or any such affiliate in the future. Employee further agrees not to pursue any such business opportunity or opportunities for his own account or for the account of any third party irrespective of the Company’s decision to exploit or not to exploit any such business opportunity.

 

12. Proprietary Rights.

 

12.1 Work Product. Employee acknowledges and agrees that all right, title, and interest in and to all writings, works of authorship, technology, inventions, discoveries, processes, techniques, methods, ideas, concepts, research, proposals, materials, and all other work product of any nature whatsoever, that are created, prepared, produced, authored, edited, amended, conceived, or reduced to practice by Employee individually or jointly with others during the employment term and relate in any way to the business or contemplated business, products, activities, research, or development of the Company or result from any work performed by Employee for the Company (in each case, regardless of when or where prepared or whose equipment or other resources is used in preparing the same), all rights and claims related to the foregoing, and all printed, physical and electronic copies, and other tangible embodiments thereof (collectively, “Work Product”) as well as any and all rights in and to US and foreign (a) patents, patent disclosures and inventions (whether patentable or not), (b) trademarks, service marks, trade dress, trade names, logos, corporate names, and domain names, and other similar designations of source or origin, together with the goodwill symbolized by any of the foregoing, (c) copyrights and copyrightable works (including computer programs), mask works, and rights in data and databases, (d) trade secrets, know-how, and other confidential information, and (e) all other intellectual property rights, in each case whether registered or unregistered and including all registrations and applications for, and renewals and extensions of, such rights, all improvements thereto and all similar or equivalent rights or forms of protection in any part of the world (collectively, “Intellectual Property Rights”), shall be the sole and exclusive property of the Company.

 

For purposes of this Agreement, Work Product includes, but is not limited to, Company information, including plans, publications, research, strategies, techniques, agreements, documents, contracts, terms of agreements, negotiations, know-how, computer programs, computer applications, software design, web design, work in process, databases, manuals, results, developments, reports, graphics, drawings, sketches, market studies, formulae, notes, communications, algorithms, product plans, product designs, styles, models, audiovisual programs, inventions, unpublished patent applications, original works of authorship, discoveries, experimental processes, experimental results, specifications, customer information, client information, customer lists, client lists, manufacturing information, marketing information, advertising information, and sales information.

 

12

 

 

12.2 Work Made for Hire; Assignment. Employee acknowledges that, by reason of being employed by the Company at the relevant times, to the extent permitted by law, all of the Work Product consisting of copyrightable subject matter is “work made for hire” as defined in 17 U.S.C. § 101 and such copyrights are therefore owned by the Company. To the extent that the foregoing does not apply, Employee hereby irrevocably assigns to the Company, for no additional consideration, Employee’s entire right, title, and interest in and to all Work Product and Intellectual Property Rights therein, including the right to sue, counterclaim, and recover for all past, present, and future infringement, misappropriation, or dilution thereof, and all rights corresponding thereto throughout the world. Nothing contained in this Agreement shall be construed to reduce or limit the Company’s rights, title, or interest in any Work Product or Intellectual Property Rights so as to be less in any respect than that the Company would have had in the absence of this Agreement. Nothing in this Section is intended to apply to any Work Product or Intellectual Property Rights which qualify fully under the provisions of Section 2870 of the California Labor Code, a copy of which is attached to this Agreement as Exhibit 1.

 

12.3 Further Assurances: Power of Attorney. During and after the employment term, the Employee agrees to reasonably cooperate with the Company to (a) apply for, obtain, perfect, and transfer to the Company the Work Product as well as any and all Intellectual Property Rights in the Work Product in any jurisdiction in the world; and (b) maintain, protect and enforce the same, including, without limitation, giving testimony and executing and delivering to the Company any and all applications, oaths, declarations, affidavits, waivers, assignments, and other documents and instruments as shall be requested by the Company. Employee hereby irrevocably grants the Company power of attorney to execute and deliver any such documents on Employee’s behalf in his name and to do all other lawfully permitted acts to transfer the Work Product to the Company and further the transfer, prosecution, issuance, and maintenance of all Intellectual Property Rights therein, to the full extent permitted by law, if Employee does not promptly cooperate with the Company’s request (without limiting the rights the Company shall have in such circumstances by operation of law). The power of attorney is coupled with an interest and shall not be affected by Employee’s subsequent incapacity.

 

12.4 No License. Employee understands that this Agreement does not, and shall not be construed to, grant the Employee any license or right of any nature with respect to any Work Product or Intellectual Property Rights or any Confidential Information, materials, software, or other tools made available to Employee by the Company.

 

13. Appearance Release. Employee irrevocably agrees that the Company may interview tape and photograph Employee, and make audio and visual recordings of his voice, conversation and sounds for use on and in connection with the Company, its Website(s), its business(es), and the advertising and promotion thereof, and that Company shall be the exclusive owner of the results and proceeds of such taping, photography and recording with the right, throughout the universe, in any media now known or hereafter devised, an unlimited number of times in perpetuity, to copyright, to use and to license others to use, in any manner, all or any portion thereof or of a reproduction thereof in connection the same or otherwise. Employee represents that any statements made by him during his appearance are true, to the best of his knowledge, and that neither they nor his appearance will violate or infringe upon the rights of any third party.

 

14. Compliance with Company Non-Disclosure Obligation. Employee hereby acknowledges that Company may hereafter be subject to nondisclosure agreements with third persons pursuant to which Company must protect or refrain from the use of proprietary information which is the property of such third persons. Employee hereby agrees upon the directive of the Company to be bound by the terms of such agreements in the event he has access to the proprietary information protected thereunder to the same extent as if he were an original individual signatory thereto.

 

13

 

 

15. Clawback Provisions. Notwithstanding any other provisions in this Agreement to the contrary, any incentive-based or other compensation paid to the Employee under this Agreement or any other agreement or arrangement with the Company which is subject to recovery under any law, government regulation, or stock exchange listing requirement will be subject to such deductions and clawback as may be required to be made pursuant to such law, government regulation, or stock exchange listing requirement (or any policy adopted by the Company pursuant to any such law, government regulation or stock exchange listing requirement).

 

16. Indemnification; Insurance. On the Commencement Date, the Employee and the Company shall enter into an indemnification agreement on the Company’s customary terms and conditions. In addition, the Company shall defend and indemnify Employee to the fullest extent allowed by law, and to provide him with coverage under any directors’ and officers’ liability insurance policies, in each case on terms not less favorable than those provided to any of its other directors and officers as in effect from time to time. In the event of any inconsistency or conflict between the provisions in this Section and any provision in any other indemnity agreement or other agreement between the parties, the provision in such other agreement shall control.

 

17. Severability. The invalidity of any one or more of the words, phrases, sentences, clauses, sections, subdivisions, subparagraphs, paragraphs or articles contained in this Agreement shall not affect the enforceability of the remaining portions of this Agreement or any part thereof, all of which are inserted conditionally on their being legally valid. In the event that one or more of the words, phrases, sentences, clauses, sections, subdivisions, subparagraphs, paragraphs or articles are determined to be unenforceable and if such invalidity shall be caused by the length of any period of time or the size of any area set forth in any part hereof, such period of time or such area, or both, shall be considered to be reduced to a period or area which would cure such invalidity.

 

18. Notice. Any notices or other communications to any party pursuant to or relating to this Agreement must be in writing and shall be deemed to have been given or delivered when (a) hand-delivered, (b) mailed through the U.S. Postal Service via certified mail, return receipt requested, postage prepaid, (c) through a nationally recognized overnight courier, or (d) electronic mail, provided a “read receipt” is obtained, to the parties at their addresses below:

 

  Company: NuZee, Inc.
    1401 Capital Ave., Suite B
    Plano, Texas 75074
     
    Attention: Masa Higashida, Chief Executive Officer
     
  with a copy to: JR Lanis Esq.
    Polsinelli
    One East Washington, Suite 1200
    Phoenix, AZ 85004

 

14

 

 

  Employee: Patrick Shearer
    [***]
    [***]

 

or such other address given by such party to the other party at any time hereafter.

 

19. Entire Agreement. This Agreement contains the sole and entire agreement between the parties with respect to the subject matter hereof and supersedes any and all other prior written or oral agreements between them as to such subject matter.

 

20. Amendment. No amendment, waiver or modification of this Agreement or any provisions of this Agreement shall be valid unless in writing and duly executed by both parties.

 

21. Binding Agreement. Except as herein set forth, this Agreement shall be binding upon and inure to the benefit of the parties and their respective heirs, legal representatives.

 

22. Waiver. Any waiver by any party of any breach of any provision of this Agreement shall not be considered as or constitute a continuing waiver or waiver of any other breach of any provision of this Agreement.

 

23. Assignment. This Agreement is personal to Employee and may not be assigned by him without Company’s prior written consent, which consent may be withheld in Company’s sole and absolute discretion.

 

24. Successors and Assigns. This Agreement shall be binding upon the parties hereto and their successors and assigns.

 

25. Captions. Captions contained in this Agreement are inserted only as a matter of convenience or for reference and in no way defines, limits, extends, or describes the scope of this Agreement or the intent of any provisions of this Agreement

 

26. Dispute Resolution; Arbitration. Any controversy or claim arising out of or relating to this Agreement, or the breach thereof, or Employee’s employment, shall be resolved by arbitration as follows:

 

26.1 Mandatory Arbitration: Company and Employee agree that any claim, complaint, or dispute that relates in any way to this Agreement or Employee’s employment with Company, whether based in contract, tort, statute, fraud, misrepresentation or any other legal theory, shall be submitted to binding arbitration administered by the American Arbitration Association (“AAA”) in accordance with its Employment Arbitration Rules & Mediation Procedures, which can be found online at https://adr.orvJsites/default/files/EmbloymentRules Web 2.pdf (the “Rules”). If the AAA Rules are inconsistent with the terms of this Agreement, the terms of this Agreement shall govern.

 

15

 

 

26.2 Covered Claims. This Agreement to arbitrate covers all grievances, disputes, claims, or causes of action (collectively, “claims”) in a federal, state or local court or agency under applicable federal, state or local laws, arising out of Employee’s employment with the Company and the termination thereof, including claims Employee may have against the Company or against its officers, directors, supervisors, managers, employees, or agents in their capacity as such or otherwise, or that the Company may have against Employee. The claims covered by this Agreement include, but are not limited to, claims for breach of any contract or covenant (express or implied), tort claims, claims for wrongful termination (constructive or actual) in violation of public policy, claims for discrimination or harassment (including, but not limited to, harassment or discrimination based on race, sex, gender, religion, national origin, age, marital status, medical condition, psychological condition, mental condition, disability, or sexual orientation), claims for violation of any federal, state, or other governmental law, statute, regulation, or ordinance, including, but not limited to, all claims arising under Title VII of the Civil Rights Act, the Age Discrimination in Employment Act, the Americans With Disabilities Act, the California Fair Employment and Housing Act, the Consolidated Omnibus Budget Reconciliation Act of 1985, and Employee Retirement Income Security Act. The parties to this Agreement specifically agree that all claims under the California Labor Code, including, but not limited to, claims for overtime, unpaid wages, and claims involving meal and rest breaks shall be subject to this Arbitration Agreement (“Covered Claims”).

 

26.3 Claims Not Covered. Claims not covered by this Agreement are claims for workers’ compensation, unemployment compensation benefits, administrative charges for unfair labor practices brought before the National Labor Relations Board, Excluded Claims (defined in Paragraph 24.4 below), or any other claims that, as a matter of law, the Parties cannot agree to arbitrate. Nothing in this Agreement shall be interpreted to mean that employees are precluded from filing complaints with the California Department of Fair Employment and Housing and/or federal Equal Employment Opportunity Commission and National Labor Relations Board.

 

26.4 Waiver of Class Action and Representative Action Claims. Except for representative claims which cannot be waived under applicable law and which are therefore excluded from this Agreement (“Excluded Claims”), Employee and the Company expressly intend and agree that: (a) class action and representative action procedures are hereby waived and shall not be asserted, nor will they apply, in any arbitration pursuant to this Agreement; (b) each will not assert class action or representative action claims against the other in arbitration or otherwise; and (c) Employee and the Company shall only submit their own, individual claims in arbitration and will not seek to represent the interests of any other person. To the extent that the parties’ dispute involves both timely filed Excluded Claims and claims subject to this Agreement, the Parties agree to bifurcate and stay for the duration of the arbitration proceedings any such Excluded Claims.

 

26.5 Waiver of Trial By Jury. The parties understand and fully agree that by entering into this Agreement to arbitrate, they are giving up their constitutional right to have a trial by jury, and are giving up their normal rights of appeal following the rendering of a decision except as California law provides for judicial review of arbitration proceedings. The Parties anticipate that by entering into this Agreement, they will gain the benefits of a speedy and less expensive dispute resolution procedure.

 

26.6 Claims Procedure. Arbitration shall be initiated upon the express written notice of either party. The aggrieved party must give written notice of any claim to the other party. Written notice of an Employee’s claim shall be mailed by certified or registered mail, return receipt requested, to the Company (at the address indicated in Paragraph 16). Written notice of the Company’s claim will be mailed to the last known address of Employee. The written notice shall identify and describe the nature of all claims asserted and the facts upon which such claims are based. Written notice of arbitration shall be initiated within the same time limitations that California law applies to those claim(s).

 

16

 

 

26.7 Arbitrator Selection. The Arbitrator shall be selected as provided in the AAA Rules.

 

26.8 Discovery. The AAA Rules regarding discovery shall apply to arbitration under this Agreement, in addition to California Code of Civil Procedure Section 1280, et seq. (including but not limited to California Code of Civil Procedure Section 1283.05), unless otherwise ordered by the Arbitrator. The Arbitrator selected according to this Agreement shall decide all discovery disputes.

 

26.9 Substantive Law. The Arbitrator shall apply the substantive state or federal law (and the law of remedies, if applicable) as applicable to the claim(s) asserted. The Arbitrator shall conduct and preside over an arbitration hearing of reasonable length, to be determined by the Arbitrator. The Arbitrator shall provide the parties with a written decision explaining his or her findings and conclusions. The Arbitrator’s decision shall be final and binding upon the parties.

 

26.10 Motions. The Arbitrator shall have jurisdiction to hear and rule on prehearing disputes and is authorized to hold prehearing conferences by telephone or in person as the Arbitrator deems necessary. The Arbitrator shall have the authority to set deadlines for completion of discovery, and for filing motions for summary judgment, and to set briefing schedules for any motions. The Arbitrator shall have the authority to adjudicate any cause of action, or the entire claim, pursuant to a motion for summary adjudication and/or summary judgment, and, in deciding such motions, shall apply the law of the State of California.

 

26.11 Compelling Arbitration/Enforcing Award. Either party may bring an action in court to compel arbitration under this Agreement or to otherwise determine the arbitrability of claims under this Agreement, and to confirm, vacate or enforce an arbitration award, and each party shall bear its own attorney fees and costs and other expenses of such action.

 

26.12 Arbitration Fees and Costs. The Company shall be responsible for the arbitrator’s fees and expenses. Each party shall pay its own costs and attorneys’ fees, if any. However, if any party prevails on a statutory claim which affords the prevailing party attorneys’ fees and costs, or if there is a written agreement providing for attorneys’ fees and costs, the Arbitrator may award reasonable attorneys’ fees and costs to the prevailing party. Any dispute as to the reasonableness of any fee or cost shall be resolved by the Arbitrator.

 

26.13 Term of Agreement. This Agreement to arbitrate shall survive the termination of Employee’s employment. It can only be revoked or modified in writing signed by both parties that specifically states an intent to revoke or modify this Agreement and is signed by the CEO and/or President.

 

27. Governing Law. This Agreement shall be governed by and construed in accordance the Employee Retirement Income Security Act of 1974, as amended (“ERISA”) to the extent applicable, and otherwise with the laws of the State of California, without regard to the law of conflicts that would require the laws of any other jurisdiction to apply, including, but not limited, to the fashioning of any federal common law that might apply under ERISA.

 

17

 

 

28. Counterparts/Facsimile. This Agreement may be signed in counterparts which, when considered together, shall be regarded as one completely signed document. This Agreement may be signed by facsimile signature, wherein a facsimile copy will have the same force and effect as an original.

 

29. Further Documents. The parties hereto agree to execute any writings, instruments or applications necessary to carry out the intent of this Agreement.

 

30. Cumulative Remedies. Except as otherwise provided in this contract all rights and remedies herein or otherwise shall be cumulative and none of them shall be in limitation of any other right or remedy.

 

31. Gender/Number. As used herein, the masculine, feminine, or neuter gender, and the singular or plural number shall each be deemed to include the others whenever the context so indicates

 

32. Construction. This Agreement shall be construed without regard to the identity of the person who drafted the various provisions hereof. Each and every provision of this Agreement shall be construed as though the parties participated equally in the drafting of the same. Consequently, the parties acknowledge and agree that any rule of construction that a document is to be construed against the drafting party shall not be applicable to this Agreement.

 

33. Indemnification. Each party hereto agrees to indemnify the other and hold the other harmless from and against any and all damages or liability including attorneys’ fees and court costs occasioned by said other party’s breach of any warranty representation or agreement contained herein.

 

[Signature page to follow on next page.]

 

18

 

 

IN WITNESS WHEREOF, the parties have executed this Agreement as of the day and year first above written.

 

  NuZee, Inc.,
  a Nevada corporation
     
  By: /s/ Masateru Higashida
  Name: Masateru Higashida
  Title: Chief Executive Officer
     
  Employee
     
  By: /s/ Patrick Shearer
  Name: Patrick Shearer
  Title: Chief Financial Officer
     
    Last 4 of SSW [***]

 

 

 

 

EXHIBIT 1

 

CALIFORNIA LABOR CODE
SECTION 2870

 

2870. (a) Any provision in an employment agreement which provides that an employee shall assign, or offer to assign, any of his or her rights in an invention to his or her employer shall not apply to an invention that the employee developed entirely on his or her own time without using the employer’s equipment, supplies, facilities, or trade secret information except for those inventions that either:

 

  1. Relate at the time of conception or reduction to practice of the invention to the employer’s business, or actual or demonstrably anticipated research or development of the employer; or
     
  2. Result from any work performed by the employee for the employer.

 

(b) To the extent a provision in an employment agreement purports to require an employee to assign an invention otherwise excluded from being required to be assigned under subdivision (a), the provision is against the public policy of this state and is unenforceable.

 

2

 

 

 

Exhibit 10.2

 

Severance Agreement and General Release

 

This Severance Agreement and General Release (“Agreement”) is entered into between NuZee, Inc. (the “Company”), and Shanoop Kothari (the “Employee”) (collectively the “Parties” and each, individually, a “Party”). All terms not otherwise defined herein shall have the same meaning as set forth in the Employee’s Employment Agreement, dated March 31, 2019 (the “Employment Agreement”), and the Parties’ Restricted Stock Award Agreement under the NuZee, Inc. 2019 Stock Incentive Plan (the “Plan”), which lists a Date of Grant of January 11, 2021 (the “Restricted Stock Award Agreement”).

 

TERMS

 

1. Termination of Employment Relationship. The Company has accepted Employee’s voluntary resignation submitted to the Company on June 22, 2021, to be effective on the earlier of August 16, 2021 or the date that the Company’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2021 (the “Form 10-Q”) is filed with the Securities and Exchange Commission (the “SEC”) (the “Separation Date”). After the Separation Date, the Employee will not represent himself as being an employee, officer, agent, or representative of the Company for any purpose. Except as otherwise set forth in this Agreement, the Separation Date is the employment termination date for the Employee for all purposes, meaning the Employee is not entitled to any further compensation, monies, or other benefits from the Company, including coverage under any benefit plans or programs sponsored by the Company, as of the Separation Date.

 

2. Return of Property. The Employee covenants and agrees that he will return on the Separation Date all Company property, including identification cards or badges, access codes or devices, keys, laptops, computers, phones, hand-held electronic devices, credit cards, electronically stored documents or files, physical files, and any other Company property in the Employee’s possession.

 

3. Supplemental Release. Employee covenants and agrees that following the conclusion of Employee’s ongoing obligations under Section 1 of this Agreement, Employee shall execute the Supplemental Release that is attached to this Agreement as Exhibit A, on the Separation Date.

 

4. Employee Representations. The Employee specifically represents, warrants, and confirms that the Employee:

 

(a) has not filed any claims, complaints, or actions of any kind against the Company with any federal, state, or local court or government or administrative agency.

 

(b) has been properly paid for all hours worked for the Company.

 

(c) has received all wages, salary, commissions, bonuses, and other compensation due to the Employee, including the Employee’s paycheck for salary through and including the date of this Agreement.

 

 

 

 

(d) has not engaged in and is not aware of any unlawful conduct relating to the business of the Company.

 

If any of these statements is not true, the Employee cannot sign this Agreement and must notify the Company immediately in writing of the statements that are not true. This notice will not automatically disqualify the Employee from receiving the benefits offered in this Agreement but will require the Company’s further review and consideration.

 

5. Consideration. As consideration for the Employee’s execution of, non-revocation of, and compliance with this Agreement, including the Employee’s waiver and release of claims in Section 6 and other post-termination obligations, the Company agrees to provide the following benefits to which the Employee is not otherwise entitled:

 

(a) Accelerated Vesting of Restricted Shares. The Company agrees to provide Employee accelerated vesting of certain shares under the Restricted Stock Award Agreement, as follows:

 

Pursuant to the Restricted Stock Award Agreement, as modified by this Agreement, the remaining outstanding one-third (1/3) or 50,737 of the total number of the Restricted Shares (152,215 Restricted Shares) granted to Employee shall vest, and the Period of Restriction with respect to such Restricted Shares will lapse, as of the Separation Date, on the condition that the Company’s Form 10-Q has been timely filed with the SEC on or before August 16, 2021.

 

(b) Health Insurance Continuation. Provided Employee timely elects continued coverage under COBRA following the Separation Date and remains eligible for such COBRA coverage under the applicable terms of the Company’s health insurance program for active employees, including major medical, dental, and vision, but excluding any self-funded group health plans (“Policy”), Company agrees to pay the cost of coverage under the Policy in effect with respect to Employee and Employee’s dependents on the Separation Date by paying the applicable COBRA premiums for the period from the Separation Date to (i) December 31, 2021; or (ii) the date that Employee ceases to be covered under COBRA under the terms of the Policy, whichever occurs first (the “Benefits Continuation Period”), but only to the extent that the premium for such COBRA coverage does not otherwise qualify for the COBRA premium subsidy as determined under the America Rescue Plan Act of 2021. After the end of the Benefits Continuation Period, COBRA coverage will be made available to Employee, if applicable, at Employee’s sole expense (i.e., Employee will be responsible for the full COBRA premium), for the remaining months of COBRA coverage made available pursuant to applicable law and the terms of the Policy. This benefits provided under this paragraph do not expand or extend the maximum period of COBRA coverage to which Employee would otherwise be entitled under applicable law. The foregoing notwithstanding, the benefits provided under this paragraph shall cease if Employee becomes employed during the Benefits Continuation Period by an employer which offers group medical insurance coverage to its employees when Employee becomes eligible for such coverage. Employee shall promptly notify the Company as to whether and when such group health insurance benefits are available.

 

 

 

 

(c) Employee Forfeiture. Should the Employee violate the terms of this Agreement prior to the Separation Date, the Employee forfeits any claim to the unvested Restricted Shares. In addition, the right to any accelerated vesting of the Restricted Shares as described in this Agreement is expressly conditioned upon entering into the Agreement. The Employee shall forfeit any right to accelerated vesting in the event the Agreement is rescinded in accordance with Section 6(b)(vii) below.

 

(d) Employee Acknowledgment. The Employee understands, acknowledges, and agrees that the benefits set forth in this Section 5 exceed what the Employee is otherwise entitled to receive on separation from employment, and that these benefits are being given as consideration in exchange for executing this Agreement, including the general release and protective covenants contained in it. The Employee further acknowledges that the Employee is not entitled to any additional payment or consideration not specifically referenced in this Agreement. Nothing in this Agreement shall be deemed or construed as an express or implied policy or practice of the Company to provide these or other benefits to any individuals other than the Employee. Employee specifically acknowledges and agrees that (i) the Company has made no representations to Employee regarding the tax consequences of any amounts received by Employee or for Employee’s benefit pursuant to this Agreement, and (ii) Employee has not relied on any representation or lack of representation by the Company. Employee remains wholly responsible for the tax consequences regarding the amounts to be received.

 

6. Release and Waiver of Claims.

 

(a) Employee’s General Release and Waiver of Claims. In exchange for the consideration provided in this Agreement within sixty (60) days following the Separation Date, the Employee and the Employee’s heirs, executors, representatives, administrators, agents, insurers, and assigns (collectively, the “Releasors”) irrevocably and unconditionally fully and forever waive, release, and discharge the Company, including the Company’s parents, subsidiaries, affiliates, predecessors, successors, and assigns, and each of its and their respective officers, directors, employees, shareholders, trustees, and partners, in their corporate and individual capacities (collectively, the “Released Parties”), from any and all claims, demands, actions, causes of actions, judgments, rights, fees, damages, debts, obligations, liabilities, and expenses (inclusive of attorneys’ fees) of any kind whatsoever, whether known or unknown (collectively, “Released Claims”), that the Releasors may have or have ever had against the Released Parties, or any of them, by reason of any actual or alleged act, omission, transaction, practice, conduct, occurrence, or other matter from the beginning of time up to and including the date of the Employee’s execution of this Agreement, including but not limited to:

 

(i) any and all claims under Title VII of the Civil Rights Act of 1964, the Americans with Disabilities Act, the Family and Medical Leave Act (regarding existing but not prospective claims), the Equal Pay Act, the Employee Retirement Income Security Act (regarding unvested benefits), the Civil Rights Act of 1991, Section 1981 of U.S.C. Title 42, the Fair Credit Reporting Act, the Worker Adjustment and Retraining Notification Act, the National Labor Relations Act, the Age Discrimination in Employment Act (“ADEA”), the Older Workers’ Benefits Protection Act (“OWBPA”), the Uniform Services Employment and Reemployment Rights Act, the Genetic Information Nondiscrimination Act, the Immigration Reform and Control Act, the Texas Commission on Human Rights Act; Chapter 451 of the Texas Labor Code; the Texas Payday Law; the Texas Health and Safety Code; the Texas Occupational Health and Safety Law; the Texas Juror Protection Law; Chapter 431 of the Texas Government Code; Chapter 431 of the Texas Government Code; the Texas Hazard Communication Act, all including any amendments and their respective implementing regulations, and any other federal, state, local, or foreign law (statutory, regulatory, or otherwise) that may be legally waived and released; however, the identification of specific statutes is for purposes of example only, and the omission of any specific statute or law shall not limit the scope of this general release in any manner.

 

 

 

 

(ii) any and all claims arising under tort, contract, and quasi-contract, including but not limited to claims of breach of an express or implied contract, wrongful or retaliatory discharge, fraud, defamation, negligent or intentional infliction of emotional distress, tortious interference with a contract or prospective business advantage, breach of the implied covenant of good faith and fair dealing, promissory estoppel, detrimental reliance, invasion of privacy, false imprisonment, nonphysical injury, personal injury or sickness, or any other harm.

 

(iii) any and all claims for compensation of any type whatsoever, including but not limited to claims for wages, salary, bonuses, commissions, incentive compensation, vacation, sick pay, and severance that may be legally waived and released.

 

(iv) any and all claims for monetary or equitable relief, including but not limited to attorneys’ fees, back pay, front pay, reinstatement, expert fees, medical fees or expenses, costs and disbursements, punitive damages, liquidated damages, and penalties.

 

(v) indemnification rights the Employee has against the Company.

 

However, this general release and waiver of claims excludes, and the Employee does not waive, release, or discharge: (i) any right to file an administrative charge or complaint with, or testify, assist, or participate in an investigation, hearing, or proceeding conducted by the Equal Employment Opportunity Commission, the Texas Workforce Commission, or other similar federal, state, or local administrative agencies, although the Employee waives any right to monetary relief related to any filed charge or administrative complaint; (ii) claims that cannot be waived by law, such as claims for unemployment benefit rights and workers’ compensation; (iii) any right to file an unfair labor practice charge under the National Labor Relations Act; and (iv) any rights to vested benefits, such as pension or retirement benefits, the rights to which are governed by the terms of the applicable plan documents and award agreements.

 

 

 

 

(b) ADEA/OWBPA Waiver. In further consideration of the payments and benefits provided to the Employee in this Agreement within sixty (60) days following the Separation Date, the Releasors irrevocably and unconditionally fully and forever waive, release, and discharge the Released Parties from any and all Released Claims, whether known or unknown, from the beginning of time through the date of the Employee’s execution of this Agreement arising under the ADEA and OWBPA. By signing this Agreement, the Employee acknowledges and confirms that:

 

(i) the Employee has read this Agreement in its entirety and understands all of its terms.

 

(ii) by this Agreement, the Employee has been advised in writing to consult with an attorney of the Employee’s choosing before signing this Agreement.

 

(iii) the Employee knowingly, freely, and voluntarily agrees to all of the terms and conditions set out in this Agreement, including, without limitation, the waiver, release, and covenants contained in it.

 

(iv) the Employee is signing this Agreement, including the waiver and release, in exchange for good and valuable consideration in addition to anything of value to which the Employee is otherwise entitled.

 

(v) the Employee was given at least twenty-one (21) days to consider the terms of this Agreement and consult with an attorney of the Employee’s choice, although the Employee may sign it sooner if desired; changes to this Agreement, whether material or immaterial, do not restart the running of the 21-day period.

 

(vi) the Employee understands that the Employee has seven (7) days after signing this Agreement to revoke the release in this paragraph by hand-delivering or mailing a notice of revocation to the Company before the end of this seven-day period. If mailed, the revocation must be postmarked within the seven (7) calendar day period, properly addressed to Company, and sent by certified mail, return receipt requested. This Agreement becomes effective after the expiration of the revocation period set forth above (the “Effective Date”).

 

(vii) the Employee understands that the release does not apply to rights and claims that may arise after the Employee signs this Agreement.

 

 

 

 

(viii) the Employee understands, acknowledges and agrees that this Agreement shall be void, and no benefits shall be provided under this Agreement by the Company if the release is not properly signed and returned to the Company by the Employee within sixty (60) days from the Separation Date.

 

7. Post-Termination Obligations and Protective Covenants. The Employee stipulates and agrees to the following:

 

(a) Acknowledgment. The Employee understands and acknowledges that by virtue of the Employee’s employment with the Company, the Employee had access to and knowledge of Confidential Information (defined below), was in a position of trust and confidence with the Company, and benefitted from the Company’s goodwill. The Employee understands and acknowledges that the Company invested significant time and expense in developing the Confidential Information and goodwill.

 

The Employee further understands and acknowledges that the protective covenants below are necessary to protect the Company’s legitimate business interests in its Confidential Information and goodwill. The Employee further understands and acknowledges that the Company’s ability to reserve these for the exclusive knowledge and use of the Company is of great competitive importance and commercial value to the Company and that the Company would be irreparably harmed if the Employee violates the protective covenants below.

 

(b) Confidential Information. The Employee understands and acknowledges that during the course of employment with the Company, the Employee has had access to and learned about confidential, secret, and proprietary documents, materials, and other information, in tangible and intangible form, of and relating to the Company and its businesses and existing and prospective customers, suppliers, investors, and other associated third parties (“Confidential Information”). The Employee further understands and acknowledges that this Confidential Information and the Company’s ability to reserve it for the exclusive knowledge and use of the Company is of great competitive importance and commercial value to the Company, and that improper use or disclosure of the Confidential Information by the Employee may cause the Company to incur financial costs, loss of business advantage, liability under confidentiality agreements with third parties, civil damages, and criminal penalties.

 

For purposes of this Agreement, Confidential Information includes, but is not limited to, all information not generally known to the public, in spoken, printed, electronic, or any other form or medium, relating directly or indirectly to: business processes, practices, methods, policies, plans, publications, documents, research, operations, services, strategies, techniques, agreements, contracts, terms of agreements, transactions, potential transactions, negotiations, pending negotiations, know-how, trade secrets, computer programs, computer software, applications, operating systems, software design, web design, work-in-process, databases, device configurations, embedded data, compilations, metadata, algorithms, technologies, manuals, records, articles, systems, material, sources of material, supplier information, vendor information, financial information, results, accounting information, accounting records, legal information, marketing information, advertising information, pricing information, credit information, design information, payroll information, staffing information, personnel information, employee lists, supplier lists, vendor lists, developments, reports, internal controls, security procedures, graphics, drawings, sketches, market studies, sales information, revenue, costs, formulae, notes, communications, product plans, designs, styles, models, ideas, audiovisual programs, inventions, unpublished patent applications, original works of authorship, discoveries, experimental processes, experimental results, specifications, customer information, customer lists, client information, client lists, manufacturing information, factory lists, distributor lists, and buyer lists of the Company or its businesses or any existing or prospective customer, supplier, investor, or other associated third party, or of any other person or entity that has entrusted information to the Company in confidence.

 

 

 

 

The Employee understands that the above list is not exhaustive, and that Confidential Information also includes other information that is marked or otherwise identified or treated as confidential or proprietary, or that would otherwise appear to a reasonable person to be confidential or proprietary in the context and circumstances in which the information is known or used.

 

The Employee understands and agrees that Confidential Information developed by the Employee in the course of the Employee’s employment by the Company is subject to the terms and conditions of this Agreement as if the Company furnished the same Confidential Information to the Employee in the first instance. Confidential Information shall not include information that is generally available to and known by the public at the time of disclosure to the Employee, provided that the disclosure is through no direct or indirect fault of the Employee or person acting on the Employee’s behalf.

 

(c) Disclosure and Use Restrictions. The Employee agrees and covenants:

 

(i) to treat all Confidential Information as strictly confidential.

 

(ii) not to directly or indirectly disclose, publish, communicate, or make available Confidential Information, or allow it to be disclosed, published, communicated, or made available, in whole or part, to any entity or person whatsoever (including other employees of the Company) not having a need to know and authority to know and use the Confidential Information in connection with the business of the Company and, in any event, not to anyone outside of the direct employ of the Company except with the prior consent of an authorized officer acting on behalf of the Company in each instance (and then, such disclosure shall be made only within the limits and to the extent of such consent).

 

(iii) not to access or use any Confidential Information, and not to copy any documents, records, files, media, or other resources containing any Confidential Information, or remove any such documents, records, files, media, or other resources from the premises or control of the Company, except as allowed by applicable law or with the prior consent of an authorized officer acting on behalf of the Company (and then, such disclosure shall be made only within the limits and to the extent of such law or consent).

 

 

 

 

(iv) that the Employee’s obligations under this Agreement regarding any particular Confidential Information begin immediately and shall continue after the Employee’s employment by the Company until the Confidential Information has become public knowledge other than as a result of the Employee’s breach of this Agreement or a breach by those acting in concert with the Employee or on the Employee’s behalf.

 

(d) Permitted Disclosures. Nothing in this Agreement shall be construed to prevent disclosure of Confidential Information as may be required by applicable law or regulation, or pursuant to the valid order of a court of competent jurisdiction or an authorized government agency, provided that the disclosure does not exceed the extent of disclosure required by such law, regulation, or order. The Employee shall promptly provide written notice of any such order to an authorized officer of the Company.

 

Nothing in this Agreement prohibits or restricts the Employee (or the Employee’s attorney) from initiating communications directly with, responding to an inquiry from, or providing testimony before the SEC, the Financial Industry Regulatory Authority, any other self-regulatory organization, or any other federal or state regulatory authority regarding this Agreement or its underlying facts or circumstances or a possible securities law violation.

 

(e) Notice of Immunity Under the Defend Trade Secrets Act of 2016. Notwithstanding any other provision of this Agreement, an individual shall not be held criminally or civilly liable under any federal or state trade secret law for the disclosure of a trade secret that is made in confidence to a federal, state, or local government official or to an attorney solely for the purpose of reporting or investigating a suspected violation of law. an individual shall not be held criminally or civilly liable under any federal or state trade secret law for the disclosure of a trade secret that is made in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal. an individual who files a lawsuit for retaliation by an employer for reporting a suspected violation of law may disclose the trade secret to the attorney of the individual and use the trade secret information in the court proceeding, if the individual files any document containing the trade secret under seal; and, does not disclose the trade secret, except pursuant to court order. nothing in this agreement is intended to conflict with 18 U.S.C. § 1833(b) or create liability for disclosures of trade secrets that are expressly allowed by 18 U.S.C. § 1833(b).

 

8. Non-Disparagement. The Employee agrees and covenants that the Employee shall not at any time make, publish, or communicate to any person or entity or in any public forum any defamatory, maliciously false, or disparaging remarks, comments, or statements concerning the Company or its businesses, or any of its employees, officers, or directors, and its existing and prospective customers, suppliers, investors, and other associated third parties, now or in the future. To the extent this Agreement limits Employee’s waivable right to free speech, right to petition, or right of association, Employee expressly waives certain rights that Employee may otherwise have under the First Amendment of the United States Constitution and rights afforded by and state constitution—including, but not limited to, any remedies available under Tex. Civ. Prac. & Rem. Code Ann. §§ 27.001, et seq.

 

 

 

 

9. Remedies. In the event of a breach or threatened breach by the Employee of Section 7 or 8 of this Agreement, the Employee hereby consents and agrees that money damages would not afford an adequate remedy and that the Company shall be entitled to seek a temporary or permanent injunction or other equitable relief against such breach or threatened breach from any court of competent jurisdiction, without the necessity of showing any actual damages, and without the necessity of posting any bond or other security. Any equitable relief shall be in addition to, not in lieu of, legal remedies, monetary damages, or other available relief.

 

If the Employee fails to comply with any of the terms of this Agreement or post-employment obligations contained in it, the Company may, in addition to any other available remedies, reclaim any amounts paid to the Employee under the provisions of this Agreement and terminate any benefits or payments that are later due under this Agreement, without waiving the releases provided in it.

 

The Parties mutually agree that this Agreement can be specifically enforced in court and can be cited as evidence in legal proceedings alleging breach of the Agreement.

 

10. Successors and Assigns. The Company may freely assign this Agreement at any time. This Agreement shall inure to the benefit of the Company and its successors and assigns. The Employee may not assign this Agreement in whole or in part. Any purported assignment by the Employee shall be null and void from the initial date of the purported assignment.

 

11. Arbitration. The Parties agree that any dispute, controversy, or claim arising out of or related to Employee’s employment with Company or termination of employment, this Agreement, or any alleged breach of this Agreement, shall be governed by the Federal Arbitration Act and submitted to and decided by binding arbitration in Dallas, Texas before a single arbitrator. Arbitration shall be administered by the American Arbitration Association (“AAA”) in accordance with its Employment Arbitration Rules and Mediation Procedures, which can be found here: https://adr.org/sites/default/files/EmploymentRules_Web_2.pdf. The Company will pay the arbitrator’s fees and arbitration expenses and any other costs unique to the arbitration hearing. Discovery in any arbitration proceeding shall be conducted according to AAA’s Employment Arbitration Rules and Mediation Procedures.

 

Any arbitral award determination shall be final and binding on the Parties and may be entered as a judgment in a court of competent jurisdiction. Nothing in this Agreement shall prevent either the Employee or the Company from obtaining injunctive relief in court to prevent irreparable harm pending the conclusion of any such arbitration. This agreement to arbitrate is freely negotiated between the Employee and the Company and is mutually entered into between the parties. By entering into this Agreement, the Parties are waiving all rights to have their disputes heard or decided by a jury or in a court trial.

 

12. Governing Law, Jurisdiction, and Venue. This Agreement and all matters arising out of or relating to this Agreement and Employee’s employment or termination of employment with Company, whether sounding in contract, tort, or statute, for all purposes shall be governed by and construed in accordance with the Employee Retirement Income Security Act of 1974, as amended (“ERISA”) to the extent applicable, and otherwise the laws of Texas without regard to any conflicts of laws principles that would require the laws of any other jurisdiction to apply, including, but not limited, to the fashioning of any federal common law that might apply under ERISA. Any action or proceeding by either of the Parties not covered by Section 11, above, shall be brought in any state or federal court located in the State of Texas, County of Dallas. The Parties irrevocably submit to the exclusive jurisdiction of these courts for such matters and waive the defense of inconvenient forum to the maintenance of any action or proceeding in such venue.

 

 

 

 

13. Entire Agreement. This Agreement constitutes the entire understanding between the Parties on the subject matter contained herein and supersedes all negotiations, representations, prior discussions and preliminary agreements between the Parties with respect to the subject matter herein. This Agreement does not supersede any agreements, including, but not limited to, the Restricted Stock Award Agreement (except as otherwise provided in Section 5(a) of this Agreement) or any protective covenants that were in effect immediately prior to the date of this Agreement and which, by their terms, survive the termination of Employee’s employment. For the avoidance of doubt, nothing herein shall supersede nor replace Paragraph 6 or Paragraph 7 of the Employment Agreement, which remain ongoing for the duration defined therein.

 

14. Modification and Waiver. No provision of this Agreement may be amended or modified unless the amendment or modification is agreed to in writing and signed by the Employee the Company. No waiver by either Party of any breach by the other Party of any condition or provision of this Agreement to be performed by the other Party shall be deemed a waiver of any similar or dissimilar provision or condition at the same or any prior or subsequent time, nor shall the failure of or delay by either Party in exercising any right, power, or privilege under this Agreement operate as a waiver to preclude any other or further exercise thereof or the exercise of any other such right, power, or privilege.

 

15. Severability. If any provision of this Agreement is found by a court or arbitral authority of competent jurisdiction to be invalid, illegal, or unenforceable in any respect, or enforceable only if modified, such finding shall not affect the validity of the remainder of this Agreement, which shall remain in full force and effect and continue to be binding on the Parties.

 

The Parties further agree that any such court or arbitral authority is expressly authorized to modify any such invalid, illegal, or unenforceable provision of this Agreement instead of severing the provision from this Agreement in its entirety, whether by rewriting, deleting, or adding to the offending provision, or by making such other modifications as it deems necessary to carry out the intent and agreement of the Parties as embodied in this Agreement to the maximum extent permitted by law. Any such modification shall become a part of and treated as though originally set forth in this Agreement. If such provision or provisions are not modified, this Agreement shall be construed as if such invalid, illegal, or unenforceable provisions had not been set forth in it. The Parties expressly agree that this Agreement as so modified by the court or arbitral authority shall be binding on and enforceable against each of them.

 

16. Interpretation. Captions and headings of the sections and paragraphs of this Agreement are intended solely for convenience, and no provision of this Agreement is to be construed by reference to the caption or heading of any section or paragraph. This Agreement shall not be construed against either Party as the author or drafter of the Agreement.

 

 

 

 

17. Counterparts. The Parties may execute this Agreement in counterparts, each of which shall be deemed an original, and all of which taken together shall constitute one and the same instrument. Delivery of an executed counterpart’s signature page of this Agreement, by facsimile, email in portable document format (.pdf), or by any other electronic means intended to preserve the original graphic and pictorial appearance of a document, has the same effect as delivery of an executed original of this Agreement.

 

18. No Admission of Liability. Nothing in this Agreement shall be construed as an admission by the Company of any wrongdoing, liability, or noncompliance with any federal, state, city, or local rule, ordinance, statute, common law, or other legal obligation. The Company specifically disclaims and denies any wrongdoing or liability to the Employee.

 

19. Tolling. If the Employee violates any of the post-termination obligations in this Agreement, the obligation at issue will run from the first date on which the Employee ceases to be in violation of such obligation.

 

20. Attorneys’ Fees and Costs. If the Employee breaches any terms of this Agreement or the post-termination obligations referenced in it, to the extent authorized by Texas law, the Employee will be responsible for payment of all reasonable attorneys’ fees and costs that Company incurred in the course of enforcing the terms of this Agreement, including demonstrating the existence of a breach and any other contract enforcement efforts.

 

21. Notice of Post-Termination Obligations. When the Employee’s employment with the Company terminates, the Employee agrees to notify any subsequent employer of the protective covenants referenced in this Agreement. In addition, the Employee authorizes the Company to provide a copy of the protective covenants referenced in this Agreement to third parties, including but not limited to, the Employee’s subsequent, anticipated, or possible future employer.

 

22. Acknowledgment of Full Understanding. THE EMPLOYEE ACKNOWLEDGES AND AGREES THAT HE HAS READ, UNDERSTANDS, AND VOLUNTARILY ENTERS INTO THIS AGREEMENT. THE EMPLOYEE ACKNOWLEDGES AND AGREES THAT HE HAS HAD AN OPPORTUNITY TO ASK QUESTIONS AND CONSULT WITH AN ATTORNEY OF HIS CHOICE BEFORE SIGNING THIS AGREEMENT. THE EMPLOYEE FURTHER ACKNOWLEDGES THAT HIS SIGNATURE BELOW IS AN AGREEMENT TO RELEASE THE COMPANY FROM ANY AND ALL CLAIMS THAT CAN BE RELEASED AS A MATTER OF LAW.

 

[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]

 

 

 

 

IN WITNESS WHEREOF, the Parties have executed this Agreement as of the dates noted below.

 

Shanoop Kothari   NuZee, Inc.
         
By: /s/ Shanoop Kothari   By: /s/ Masateru Higashida
         
Name: Shanoop Kothari   Name: Masateru Higashida
         
Date: July 2, 2021   Title: Chief Executive Officer
         
      Date: July 2, 2021

 

 

 

 

Exhibit A

 

(to be executed on the Separation Date)

 

SUPPLEMENTAL RELEASE

 

Pursuant to the Severance Agreement and General Release (the “Agreement”) previously executed by Shanoop Kothari (“Kothari”), and for and in consideration of receipt of the Accelerated Vesting of Restricted Shares (the “Resignation Benefit”) contemplated in the Agreement, Kothari hereby executes this Supplemental Release on ___________________, 2021 (the “Effective Date) and agrees as follows:

 

  (1) Kothari expressly and unconditionally, on behalf of himself, and his heirs, assigns, attorneys, successors, representatives, and other agents (collectively referred to as the “Releasing Parties”), fully and completely releases, acquits, and forever discharges and holds harmless NuZee, Inc. (the “Company”) and all of its parent, subsidiary, affiliated, predecessor or successor companies, and each of their respective current and former owners, shareholders, partners, agents, employees, insurers, reinsurers, attorneys, successors, assigns, and other representatives (each a “Released Party,” and “collectively referred to as the “Released Parties”), of and from any and all claims, demands, actions, causes of action, suits, debts, contracts, agreements, promises, liabilities, compensation, bonuses, losses, costs, expenses and damages of any kind or character whatsoever, including any claims arising out of Kothari’s own negligence (collectively “Claims”), accrued or unaccrued, known or unknown, foreseen or unforeseen, in law or in equity, whether based on contract, tort, common law, or federal, state, or local statute, regulation, ordinance or executive order, arising directly or indirectly from his employment with any of the Released Parties, or relating to any matter or thing which has occurred or has failed to occur as of the Effective Date of this Supplemental Release. This release includes, but is not limited to: (i) all Claims for salary, wages, bonuses, commissions, accrued vacation benefits/paid time off, leave, reimbursable expenses, outplacement costs, fees, back pay, front pay, retirement or pension contributions, reinstatement or other equitable relief, damages, interest, retaliation, mental anguish, liquidated damages, intentional torts, defamation, punitive damages, attorneys’ fees, interest, costs or other expenses, and any and all other claims resulting thereby; (ii) any actions, inaction, representations, omissions, or commissions by the Released Parties before the Effective Date of this Supplemental Release; and (iii) any claim that acceptance of this Supplemental Release was induced by any fraudulent or negligent act or omission or results in or from any actual or constructive fraud, negligent misrepresentation, breach of fiduciary duty, breach of confidential relationship, or a breach of any other duty under law or in equity. Except to the extent as may be specifically provided in this Supplemental Release, this release is intended to be a general release of all claims, so, to the extent Kothari may be deemed to still possess any viable claims or causes of action against the Released Parties, Kothari hereby assigns to the Released Parties all Claims Kothari may have of any kind against the Released Parties, provided, however, that:
       
    (a) this release does not waive or release: (i) claims that cannot be released or waived as a matter of applicable federal, state or local law; (ii) vested benefits under the Released Parties’ retirement plans; (iii) events occurring after the date Kothari executes this Supplemental Release; or (iv) enforcing the terms of this Agreement; and

 

 

 

 

    (b) nothing in this Agreement, prohibits Kothari from reporting possible violations of law or regulation to or filing charges with any governmental agency or entity, including without limitation the United States Department of Justice, the Securities and Exchange Commission, the Equal Employment Opportunity Commission, the National Labor Relations Board, the Occupational Safety and Health Commission, any Inspector General, or any similar state or local agency, or from making other disclosures that are protected under the whistleblower provisions of federal, state or local law or regulation. Kothari does not need the prior authorization of the Released Parties to make any such reports or disclosures and Kothari is not required to notify the Released Parties that he has made such reports or disclosures. However, by signing this Supplemental Release, except as otherwise prohibited by law, Kothari waives the right to any monetary recovery in connection with a local, state or federal governmental agency proceeding or investigation, even where the law may provide for Kothari to obtain a portion of any monetary recovery, and Kothari waives the right to file a claim seeking monetary damages in any court, administrative agency or arbitral tribunal;

 

  (2) Kothari hereby certifies that he has returned to the Company the originals and all copies of all records, data, documents, notebooks, specifications, drawings, blueprints, equipment, notes, reports, business plans, customer lists, customer information, pricing information, marketing materials and information, credit cards, proprietary information, or other property of the Released Parties and has not retained copies of any such property; and
     
  (3) Kothari hereby certifies, acknowledges, and represents that he has been paid or provided all salary, wages, bonuses, commissions, accrued vacation benefits/paid time off, leave, reimbursable expenses, outplacement costs, fees, interest, and any and all other benefits and compensation due to him.

 

Dated: ________________, 2021    
    Shanoop Kothari

 

 

 

 

 

Exhibit 10.3

 

NUZEE, INC.

STOCK OPTION AGREEMENT

(2019 Stock Incentive Plan)

 

Nonqualified Stock Options

 

This Stock Option Agreement (the “Agreement”) is entered into as of [_____________], 20[__], by and between NuZee, Inc., a Nevada corporation (“the Company”), and [__________] (“Optionee”) pursuant to the Company’s 2019 Stock Incentive Plan (the “Plan”). Any capitalized term not defined in this Agreement shall have the same meaning ascribed to it in the Plan.

 

1. Grant of Option. The Company hereby grants to Optionee an option (the “Option”) to purchase all or any portion of a total of [__________] shares of the Common Stock of the Company (the “Shares”) at a purchase price of $[___] per share (the “Exercise Price”), subject to the terms and conditions set forth herein and the provisions of the Plan. This Option is not intended to qualify as an “incentive stock option” as defined in Section 422 of the Code but shall constitute a nonqualified stock option.

 

2. Vesting of Option. No portion of this Option may be exercised until such portion shall have become exercisable. The grant date of the Option is [__________], 20[___] (the “Grant Date”). The right to exercise this Option shall vest pursuant to the vesting terms set forth in this Section 2. The Option will become vested and exercisable with respect to:

 

(a) [_____] Shares upon the Company’s achievement of [__________];

 

(b) [_____] Shares upon the Company’s achievement of [__________]; and

 

(c) [_____] Shares upon the Company’s achievement of [__________].

 

The Committee shall, on an annual basis and in its sole discretion: (i) determine whether the applicable vesting terms set forth herein were satisfied and (ii) approve the actual amount of Shares that vested in the applicable fiscal year, in each case as promptly as practicable following the Company’s public filing of its audited financial statements for the applicable fiscal year. In the event that any applicable performance target is not satisfied in a respective fiscal year, the Shares that would have vested in the applicable fiscal year shall be forfeited, regardless of whether any performance targets are satisfied in any subsequent fiscal year.

 

No additional Shares shall vest after the date on which Optionee’s relationship as a Service Provider terminates, but this Option shall continue to be exercisable in accordance with Section 3 below with respect to that number of Shares that have vested as of the date on which Optionee’s relationship as a Service Provider terminates.

 

3. Term of Option. Optionee’s right to exercise this Option shall terminate upon the first to occur of the following:

 

a. the expiration of ten (10) years from the date of this Agreement;

 

 

 

 

b. the expiration of three (3) months from the date of termination of Optionee’s relationship as a Service Provider if such termination occurs for any reason other than permanent Disability, death or for Cause; provided, however, that if Optionee dies during such three-month period the provisions of Section 3(d) below shall apply;
     
c. the expiration of twelve (12) months from the date of termination of Optionee’s relationship as a Service Provider if such termination is due to permanent Disability of Optionee;
     
d. the expiration of twelve (12) months from the date of termination of Optionee’s relationship as a Service Provider if such termination is due to Optionee’s death or if death occurs during the three month period following termination of Optionee’s relationship as a Service Provider pursuant to Section 3(b) above, as the case may be;
     
e. upon the consummation of a Change in Control, unless otherwise provided pursuant to Section 8 below; or
     
f. Optionee’s relationship as a Service Provider is terminated for Cause;

 

4. Exercise of Option. On or after the vesting of any portion of this Option in accordance with Sections 2 or 8 hereof, and until termination of the right to exercise this Option in accordance with Section 3 above, the portion of this Option which has vested may be exercised in whole or in part by Optionee (or, after his or her death, by the person designated in Section 5 below) upon delivery of the following to the Company at its principal executive offices:

 

a. A written notice of exercise which identifies this Agreement and states the number of Shares then being purchased (but no fractional Shares may be purchased);
     
b. A payment of the exercise price for Shares the Optionee is purchasing, to the extent permitted by law, in one of the following forms:

 

i. A check or cash;
     
ii. By a “net exercise” arrangement pursuant to which the Company will reduce the number of Shares issued upon exercise of the Option by the largest whole number of Shares with a Fair Market Value that does not exceed the aggregate exercise price. The Optionee must pay any remaining balance of the aggregate exercise price not satisfied by the “net exercise” in cash or other permitted form of payment;
     
iii. By delivery to the Company (either by actual delivery or attestation) of previously owned Shares that are owned free and clear of any liens, claims, encumbrances or security interests. The Fair Market Value of the Shares will be determined as of the effective date of the option exercise. The Option may not be exercised by delivery to the Company of previously owned Shares if doing so would violate the provisions of any law, regulation or agreement restricting the redemption of the Company’s Share; or
     
iv. A combination of (i), (ii) or (iii) above.

 

 

 

 

c. Payment of the amount reasonably requested by the Company to satisfy the Company’s withholding obligations under federal, state or other applicable tax laws with respect to the taxable income, if any, recognized by Optionee in connection with the exercise of this Option. The Optionee may arrange to pay any withholding taxes that may be due as a result of the Option exercise pursuant to the following methods, in accordance with the terms of the Plan: (i) by payment by cash or check, (ii) by the withholding of Shares issuable upon exercise of this Option with a Fair Market Value no greater than the minimum amount required to be withheld by law, or (iii) by the delivery of Shares previously owned by the Optionee with a Fair Market Value no greater than the minimum amount required to be withheld by law. The Fair Market Value of withheld or surrendered Shares, determined as of the date when taxes otherwise would have been withheld in cash, will be applied to the withholding taxes; and
     
d. Any agreement, statement or other evidence that the Company may require to satisfy itself that the issuance of Shares upon exercise of the Option (and any subsequent resale of the Shares) will be in compliance with applicable laws and regulations.

 

The Shares issued upon exercise of the Option shall be transferred to Optionee on the records of the Company or of the transfer agent upon compliance to the satisfaction of the Committee with all requirements under applicable laws or regulations in connection with such transfer and with the requirements of this Agreement and the Plan. The determination of the Committee as to such compliance shall be final and binding on Optionee.

 

5. Death of Optionee; No Assignment. The rights of Optionee under this Agreement may not be assigned or transferred except by will or by the laws of descent and distribution, and may be exercised during the lifetime of Optionee only by such Optionee. Any attempt to sell, pledge, assign, hypothecate, transfer or dispose of this Option in contravention of this Agreement or the Plan shall be void and shall have no effect. If Optionee’s relationship as a Service Provider terminates as a result of his or her death, and provided Optionee’s rights hereunder shall have vested pursuant to Section 2 above, Optionee’s legal representative, his or her legatee, or the person who acquired the right to exercise this Option by reason of the death of Optionee (individually, a “Successor”) shall succeed to Optionee’s rights and obligations under this Agreement. After the death of Optionee, only a Successor may exercise this Option.

 

6. Incorporation of Plan. Notwithstanding anything herein to the contrary, the Option shall be subject to and governed by all the terms and conditions of the Plan, including the powers of the Committee. Optionee acknowledges receipt of a copy of the Plan.

 

7. Adjustments Upon Changes in Capital Structure. In the event that the outstanding Shares are hereafter increased or decreased or changed into or exchanged for a different number or kind of shares or other securities of the Company by reason of a recapitalization, stock split, combination of shares, reclassification, stock dividend or other change in the capital structure of the Company, then appropriate adjustment shall be made by the Committee to the number of Shares subject to the unexercised portion of this Option and to the Exercise Price per share, in order to preserve, as nearly as practical, but not to increase, the benefits of Optionee under this Option, in accordance with the provisions of the Plan.

 

 

 

 

8. Change in Control. In the event of a merger, consolidation or similar transaction directly or indirectly involving the Company that results in a Change in Control of the Company:

 

a. Notwithstanding Section 2 above, provided Optionee has not ceased to be a Service Provider from the Grant Date through the effective date of the Change in Control, the right to exercise this Option shall accelerate automatically and vest in full effective as of immediately prior to the consummation of such a Change in Control unless this Option is to be assumed by the acquiring or successor entity (or parent thereof) or new options or new incentives are to be issued in exchange therefor, as provided in subsection (b) below. If vesting of this Option will accelerate, the Committee in its discretion may provide, in connection with the Change in Control transaction, for the purchase or exchange of this Option for an amount of cash or other property having a value equal to the difference between: (x) the value of the cash or other property that Optionee would have received pursuant to the Change in Control transaction in exchange for the Shares issuable upon exercise of this Option had this Option been exercised immediately prior to the Change in Control, and (y) the aggregate Exercise Price for such Shares. If the vesting of this Option will accelerate, the Committee shall cause written notice of the Change in Control transaction to be given to Optionee not less than fifteen (15) days prior to the anticipated effective date of the proposed transaction.
     
b. The vesting of this Option shall not accelerate if and to the extent that:

 

i. this Option (including the unvested portion thereof) is to be assumed by the acquiring or successor entity (or parent thereof) or a new option of comparable value is to be issued in exchange therefor pursuant to the terms of the Change in Control transaction, or
     
ii. this Option (including the unvested portion thereof) is to be replaced by the acquiring or successor entity (or parent thereof) with new incentives containing such terms and provisions as the Committee in its discretion may consider equitable. If this Option is assumed, or if a new option of comparable value is issued in exchange therefor, then this Option or the new option shall be appropriately adjusted, concurrently with the Change in Control, to apply to the number and class of securities or other property that Optionee would have received pursuant to the Change in Control transaction in exchange for the Shares issuable upon exercise of this Option had this Option been exercised immediately prior to the Change in Control, and appropriate adjustment also shall be made to the Exercise Price such that the aggregate Exercise Price of this Option or the new option shall remain the same as nearly as practicable and in a manner satisfying the provisions of Sections 409A and 424 of the Code.

 

c. If the provisions of subsection (b) above apply, then this Option, the new option or the new incentives shall continue to vest in accordance with the provisions of Section 2 above and shall continue in effect for the remainder of the term of this Option in accordance with the provisions of Section 3 above. However, in the event of an Involuntary Termination (as defined below) of Optionee’s relationship as an Employee on or following such Change in Control, then vesting of this Option, the new option or the new incentives shall accelerate in full automatically effective upon such Involuntary Termination.

 

 

 

 

d. As defined and used for purposes of this Agreement, the following terms shall have the meanings set forth below:

 

i. “Involuntary Termination” shall mean the termination of Optionee’s relationship as an Employee for any reason other than (i) termination for Cause or (ii) the Optionee’s voluntary resignation (unless such resignation is at the request of the acquirer in which case the Optionee’s termination will deemed involuntary).
     
ii. A “Change in Control” of the Company (A) shall be as defined in Section 13.6(a) or 13.6(c) of the Plan, and (B) shall not have the meaning given under Section 13.6(b) of the Plan.

 

9. No Agreement to Employ. Nothing in this Agreement shall be construed as granting to Optionee any right with respect to the continuance of any relationship that Optionee might have as a Director, Consultant or Employee. To the extent applicable, the right of the Company to terminate at will Optionee’s employment or service relationship at any time (whether by dismissal, discharge or otherwise), with or without Cause, is specifically reserved.

 

10. Rights as Stockholder. Optionee (or Successor) shall not be deemed to be the holder of, or to have any of the rights of a holder with respect to, any of the Shares unless and until this Option shall have been exercised pursuant to the terms hereof, the Company or the transfer agent shall have transferred the shares to Optionee, and Optionee’s name shall have been entered as the stockholder of record on the books of the Company. Thereupon, Optionee shall have full voting, dividend and other ownership rights with respect to such Shares for which the Option has been exercised.

 

11. Market Stand-Off Agreement. If requested by the Company or the managing underwriter pursuant to any proposed public offering of the Company’s securities, Optionee hereby agrees that it shall not, directly or indirectly, sell, lend, pledge, offer, transfer, make any short sale of, sell any option or contract to purchase, contract to sell, purchase any option or contract to sell, grant any option, right or warrant for the purchase of, otherwise transfer or dispose of, or enter into any hedging or similar transaction with the same economic effect as a sale, any Shares held by Optionee immediately prior to the effectiveness of the registration statement for such public offering for a period specified by the Company or the managing underwriter for such offering, which period shall not exceed one hundred eighty (180) days following the effective date of the public offering. Optionee further agrees to execute such agreements as may be reasonably requested by the Company or the managing underwriter for such offering that are consistent with this Section 11 or that are necessary to give further effect thereto. In order to enforce the foregoing covenant, the Company may impose stop transfer instructions with respect to the Shares until the end of such period.

 

12. Notices. Any notice, demand or request required or permitted to be given under this Agreement shall be in writing and shall be deemed given when delivered personally or three (3) days after being deposited in the United States mail, as certified or registered mail, with postage prepaid, (or by such other method as the Committee may from time to time deem appropriate), and addressed, if to the Company, at its principal place of business, Attention: General Counsel, and if to Optionee, at his or her most recent address as shown in the employment or stock records of the Company.

 

13. Governing law. The validity, construction, interpretation, and effect of this Agreement shall be governed by and determined in accordance with the laws of the State of Nevada.

 

 
 

 

14. Severability. Should any provision or portion of this Agreement be held to be unenforceable or invalid for any reason, the remaining provisions and portions of this Agreement shall be unaffected by such holding.

 

15. Captions and Section Headings. Captions and section headings used herein are for convenience only, and are not part of this Agreement and shall not be used in construing it.

 

16. Entire Agreement. This Agreement and the Plan constitute the entire agreement between the parties with respect to the subject matter hereof and supersede all prior or contemporaneous written or oral agreements and understandings of the parties, either express or implied.

 

17. Attorneys’ Fees. If any party shall bring an action in law or equity against another to enforce or interpret any of the terms, covenants and provisions of this Agreement, the prevailing party in such action shall be entitled to recover reasonable attorneys’ fees and costs.

 

18. Counterparts. This Agreement may be executed in two or more counterparts, each of which shall be deemed an original and all of which together shall be deemed one instrument.

 

[SIGNATURE PAGE TO FOLLOW]

 

 

 

 

IN WITNESS WHEREOF, the parties have executed this Stock Option Agreement as of the date first above written.

 

NUZEE, INC.   OPTIONEE
         
By:     By:  
Name:                     Name:                         
Title:        

 

[Signature Page to Stock Option Agreement]

 

 

 

 

Exhibit 99.1

 

 

For Immediate Release

 

NuZee Appoints Patrick Shearer as New Chief Financial Officer

 

PLANO, Texas, July 6, 2021 /PRNewswire/ — NuZee, Inc. (NASDAQ: NUZE) (“NuZee” or “the Company”), a leading U.S. producer and co-packer of specialty single serve pour-over coffee pouches and pour over drip cups, today announced that Patrick Shearer has joined NuZee as its new Chief Financial Officer, effective immediately.

 

Mr. Shearer brings to NuZee over 25 years of experience in accounting, finance, transactions and management. Mr. Shearer has held numerous senior leadership positions during his career and has experience in a variety of industries including food and beverage. Mr. Shearer served as a Partner in the Risk and Financial Advisory Services practice of Deloitte where his primary focus areas included accounting advisory, finance, mergers, acquisitions, divestitures, and capital markets. Mr. Shearer has significant international experience having lived and worked in Japan in a professional capacity and having completed numerous cross-border projects primarily involving companies based in North America, Asia, and Europe. Mr. Shearer holds a Bachelor of Arts in Economics from the University of California, Los Angeles and is a Certified Public Accountant in the State of California.

 

Patrick Shearer said “I’m honored and excited to join NuZee and be a part of the team that is positioning the company for its next stage of projected growth and development. I look forward to joining Masa and the other recently appointed members of management in NuZee’s efforts to enhance its financial position.”

 

 

Mr. Shearer succeeds Shanoop Kothari as NuZee’s Chief Financial Officer. Mr. Kothari’s previously disclosed resignation from the Company will become effective no later than August 16, 2021. Until his departure, Mr. Kothari is expected primarily to assist with the transition to Mr. Shearer as NuZee’s new Chief Financial Officer.

 

     

 

 

Masa Higashida, President and CEO of NuZee, said, “Patrick is a great addition to our newly reconstituted executive leadership team, bringing years of experience in the finance industry. His expertise in finance, M&A and capital markets will be beneficial to NuZee, as we position our company for expected growth ahead. I also want to thank Shanoop Kothari for his significant contributions to NuZee during his time at the Company. We wish him well in his next endeavor.”

 

Forward-looking Statements

 

This press release contains forward-looking statements that are made pursuant to the safe harbor provisions within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. NuZee cautions you that such statements are simply predictions and actual events or results may differ materially. These statements reflect NuZee’s current expectations, and NuZee does not undertake to update or revise these forward looking statements, even if experience or future changes make it clear that any projected results expressed or implied in this or other NuZee statements will not be realized. Further, these statements involve risks and uncertainties, many of which are beyond NuZee’s control, which could cause actual results to differ materially from the forward-looking statements. These risks and uncertainties, many of which are beyond our control, include: NuZee’s plans to obtain funding for its operations, including funding necessary to develop, manufacture and commercialize its products; the impact to NuZee’s business from the COVID-19 global crisis; general market acceptance of and demand for NuZee’s products; and NuZee’s commercialization, marketing and manufacturing capabilities and strategy; for a description of additional factors that may cause NuZee’s actual results, performance or expectations to differ from any forward-looking statements, please review the information set forth in the “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” sections of the NuZee’s public reports and NuZee’s other filings made with the SEC.

 

About NuZee and Coffee Blenders

 

NuZee, Inc. (d/b/a Coffee Blenders®) is a specialty coffee company and a leading U.S. single-serve pour-over coffee pouch producer and co-packer. We own sophisticated packing equipment developed in Asia for single serve pour over production. We co-pack single-serve pour-over coffee and tea bag style coffees for customers in the U.S. market and also co-pack for the South Korean market.

 

###

 

Contact:

 

NuZee Media Relations

 

Tomoko Toyota

206-319-2849

Tomoko@nuzeeusa.com